We Think and Act Differently

Weekly Performance Review

Finn McGinnis | 04/15/25

Opportunity Equity Weekly Update for 4/4/2025 – 4/11/2025

The Magnificent 7 Moves Higher while Biogen Falls on Leqembi Guidance Cut

Samantha McLemore's Quarterly Letter

Samantha McLemore | 04/15/25

1Q25 Samantha's Quarterly Letter

“Everyone has a plan until they get punched in the face.” Mike Tyson

Portfolio Activity and Attribution

Christina Siegel Malbon | 04/09/25

1Q25 Portfolio Activity and Attribution

Christina Malbon, CFA, Reviews the Strategy for 1Q25

Weekly Archive

Finn McGinnis | 04/08/25

Opportunity Equity Weekly Update for 3/28/2025 – 4/4/2025

QXO Continues to Rise Following their Definitive Merger Agreement while Market Craters on Global Tariff Concerns

Investor Insights

Tyler Grason | 04/04/25

A Historic Buying Opportunity?

A Historic Buying Opportunity?

Weekly Archive

Finn McGinnis | 04/01/25

Opportunity Equity Weekly Update for 3/21/2025 – 3/28/2025

S4 Capital Rises on Earnings while Royalty Pharma Falls on Tax Headlines

Quarterly Market Review

Christina Siegel Malbon | 04/01/25

1Q25 Quarterly Market Review

Christina Malbon, CFA Discusses the Market Highlights of 1Q 2025

Hidden

| 04/01/25

Opportunity Equity Disclosures

Opportunity Equity Disclosures

Weekly Archive

Finn McGinnis | 03/26/25

Opportunity Equity Weekly Update for 3/14/2025 – 3/21/2025

IAC Rises on Upcoming Angi Spin while QXO Enters Into Definitive Merger Agreement to Acquire Beacon Roofing

News

Samantha McLemore | 03/25/25

Samantha McLemore on CNBC’s Closing Bell

Samantha McLemore on CNBC’s Closing Bell

Weekly Archive

Finn McGinnis | 03/18/25

Opportunity Equity Weekly Update for 3/7/2025 – 3/14/2025

Peloton Rises on Upgrade while Coinbase Follows Bitcoin Lower

Investor Insights

Tyler Grason | 03/11/25

The Night is Darkest Before the Dawn

The Night is Darkest Before the Dawn

Weekly Archive

Finn McGinnis | 03/11/25

Opportunity Equity Weekly Update for 2/28/2025 – 3/7/2025

Biogen Rises on Leqembi Sales Growth while Kosmos Follows Crude Prices Lower

Weekly Archive

Finn McGinnis | 03/04/25

Opportunity Equity Weekly Update for 2/21/2025 – 2/28/2025

General Motors Rises on Dividend Increase while Seadrill Falls on Earnings Miss

Investor Insights

Samantha McLemore | 02/28/25

“The Big Money is Made in the Big Moves” -Jesse Livermore

“The Big Money is Made in the Big Moves” -Jesse Livermore

Weekly Archive

Finn McGinnis | 02/25/25

Opportunity Equity Weekly Update for 2/14/2025 – 2/21/2025

Alibaba Rises on Strong Earnings while Norwegian Falls on Tax Concerns

Weekly Performance Review

Finn McGinnis | 02/19/25

Opportunity Equity Weekly Update for 2/7/2025 – 2/14/2025

Alibaba Rises on Strategic Partnership while Illumina Continues to Fall Following Earnings

Weekly Archive

Finn McGinnis | 02/11/25

Opportunity Equity Weekly Update for 1/31/2025 – 2/7/2025

Expedia Rises on Strong Earnings while Alphabet Falls on CAPEX Guide

Weekly Archive

Finn McGinnis | 02/10/25

Opportunity Equity Weekly Update for 1/24/2025 – 1/31/2025

Alibaba Rises on Latest AI Model while Nvidia Falls on DeepSeek Concerns

Weekly Archive

Finn McGinnis | 01/28/25

Opportunity Equity Weekly Update for 1/17/2025 – 1/24/2025

Dave & Buster’s Gains on Improved Expectations for Restaurant Industry while Kosmos Energy Followed Brent Prices Lower

Weekly Archive

Finn McGinnis | 01/22/25

Opportunity Equity Weekly Update for 1/10/2025 – 1/17/2025

Citi Rises on Strong Earnings while QXO Falls on Rejected Offer

Weekly Archive

Finn McGinnis | 01/14/25

Opportunity Equity Weekly Update for 1/3/2025 – 1/10/2025

Royalty Pharma Rises on Corporate Restructure while Alibaba Follows the Hang Seng Lower

Samantha McLemore's Quarterly Letter

Samantha McLemore | 01/13/25

“There is nothing so stable as change.” Bob Dylan

Samantha McLemore's Quarterly Commentary

Portfolio Activity and Attribution

Christina Siegel Malbon | 01/12/25

4Q24 Portfolio Activity and Attribution

Christina Malbon, CFA, Reviews the Strategy for 4Q24

Weekly Archive

Finn McGinnis | 01/07/25

Opportunity Equity Weekly Update for 12/27/2024 – 1/3/2025

Kosmos Rises on First Gas while Sofi Falls on Downgrade

Quarterly Market Review

Christina Siegel Malbon | 01/03/25

Quarterly Market Review 2024

Christina Malbon, CFA Discusses the Market Highlights of 2024

Weekly Archive

Finn McGinnis | 01/02/25

Opportunity Equity Weekly Update for 12/20/2024 – 12/27/2024

Kosmos Follows Crude Prices Higher while Coinbase Follows Bitcoin Lower

Weekly Archive

Finn McGinnis | 12/24/24

Opportunity Equity Weekly Update for 12/13/2024 – 12/20/2024

Bank of America Turns Bullish on Expedia while Coinbase Follows Bitcoin Lower

Investor Insights

Samantha McLemore | 12/19/24

What Does the Fed Day Swoon Mean for Markets?

Market Moves Following Fed Disappointment

Weekly Archive

Finn McGinnis | 12/18/24

Opportunity Equity Weekly Update for 12/6/2024 – 12/13/2024

Alphabet Jumps on Quantum Computing Advancements while Dave & Busters Falls on Earnings Miss

Weekly Performance Review

Finn McGinnis | 12/10/24

Opportunity Equity Weekly Update for 11/29/2024 – 12/6/2024

Amazon Rises on AWS Event while Energy Names Follow Crude Lower

Weekly Archive

Finn McGinnis | 12/03/24

Opportunity Equity Weekly Update for 11/22/2024 – 11/29/2024

Dave and Buster’s Rises on Turnaround Initiatives while General Motors Falls on Tariff Threat

Weekly Archive

Finn McGinnis | 11/26/24

Opportunity Equity Weekly Update for 11/15/2024 – 11/22/2024

QXO Rises on Potential M&A while Alphabet Falls on DOJ Proposal

Weekly Archive

Finn McGinnis | 11/19/24

Opportunity Equity Weekly Update for 11/8/2024 – 11/15/2024

Coinbase Jumps in Sympathy with Bitcoin while IAC Falls Despite a Topline Beat

Weekly Archive

Finn McGinnis | 11/12/24

Opportunity Equity Weekly Update for 11/1/2024 – 11/8/2024

Coinbase Jumps in Sympathy with Bitcoin While Green Thumb Falls on Election Concerns

Weekly Archive

Finn McGinnis | 11/06/24

Opportunity Equity Weekly Update for 10/25/2024 – 11/1/2024

Amazon Rises on Improved Margins While Crocs Falls on HeyDude Woes

News

| 11/05/24

Legendary Lessons: A Discussion with a Renowned Investor and His Successor

Watch Samantha McLemore, Bill Miller, and Marvin McIntyre participate in a panel discussion during the 2024 Forbes Shook Top Advisor Summit in Las Vegas.

Weekly Archive

Finn McGinnis | 10/31/24

Opportunity Equity Weekly Update for 10/18/2024 – 10/25/2024

General Motors Rises on Strong Earnings While Coinbase Follows Bitcoin Lower

News

| 10/23/24

SHOOK Top Takeaways

Our team attended the Forbes | SHOOK Top Advisor Summit last week. Over two days, we heard from leading investors, economists, financial advisors and industry executives who shared many invaluable insights and perspectives.

Weekly Archive

Finn McGinnis | 10/22/24

Opportunity Equity Weekly Update for 10/11/2024 – 10/18/2024

United Airlines Rises on Strong Earnings while CVS Falls on Management Change

Weekly Archive

Finn McGinnis | 10/14/24

Opportunity Equity Weekly Update for 10/4/2024 – 10/11/2024

Norwegian Jumps as Citi Gets Bullish While Dave and Buster’s Falls Despite Insider Buying

Samantha McLemore's Quarterly Letter

Samantha McLemore | 10/09/24

What Every Portfolio Needs: Underperformers

Samantha McLemore Discusses the Third Quarter of 2024

Portfolio Activity and Attribution

Christina Siegel Malbon | 10/08/24

3Q24 Portfolio Activity and Attribution

Christina Malbon, CFA, Reviews the Strategy for 3Q24

Weekly Archive

Finn McGinnis | 10/08/24

Opportunity Equity Weekly Update for 9/27/2024 – 10/4/2024

Kosmos Follows Crude Higher while Coinbase Follows Bitcoin Lower

Quarterly Market Review

Christina Siegel Malbon | 10/01/24

Quarterly Market Review 3Q 2024

Christina Malbon, CFA, Discusses the Market Highlights of the Third Quarter

Weekly Archive

Finn McGinnis | 10/01/24

Opportunity Equity Weekly Update for 9/20/2024 – 9/27/2024

Alibaba Rises on China’s Stimulus Package while Energy Names Follow Crude Prices Lower

Weekly Archive

Finn McGinnis | 09/24/24

Opportunity Equity Strategy Update for 9/13/2024 - 9/20/2024

Citi Rose on The Fed’s Rate Cut while S4 Capital Fell Despite Improved Margins

Weekly Archive

Finn McGinnis | 09/17/24

Opportunity Equity Weekly Update for 9/6/2024 – 9/13/2024

Nvidia Gains on Continued Strong Demand While Citigroup Fell on Higher Costs

Weekly Archive

Finn McGinnis | 09/10/24

Opportunity Equity Weekly Update for 8/30/2024 – 9/6/2024

Limited News on Top Contributors while OneMain Falls Despite Strong Branch Traffic

News

| 09/08/24

Barron's Interview with Samantha McLemore

Samantha McLemore Featured in Barron's

Weekly Archive

Finn McGinnis | 09/04/24

Opportunity Equity Weekly Update for 8/23/2024 – 8/30/2024

SOFI Rises on Positive MPL Data while NVDA Falls Despite Strong Earnings

Investor Insights

Tyler Grason | 09/04/24

What Goes Up Must Come Down

What Goes Up Must Come Down

Weekly Archive

Finn McGinnis | 08/27/24

Opportunity Equity Weekly Update for 8/16/2024 – 8/23/2024

Peloton Rises on Cost Improvements while Energy Names Follow Crude Prices Lower

Weekly Archive

Finn McGinnis | 08/20/24

Opportunity Equity Weekly Update for 8/9/2024 – 8/16/2024

Amazon Rises on Strong Retail Sales Report while Precigen Reiterates BLA Submission Plans

Weekly Archive

Finn McGinnis | 08/12/24

Opportunity Equity Weekly Update for 8/2/2024 – 8/9/2024

Expedia Rises on B2B Growth while Seadrill Falls on Rig Delays

Weekly Archive

Finn McGinnis | 08/05/24

Opportunity Equity Weekly Update for 7/26/2024 – 8/2/2024

Meta Rises on a Strong Q2 Results while OneMain Financial Falls on Macro Weakness

Investor Insights

Tyler Grason | 08/02/24

Markets Have Fear, the Sahm Rule is Here

Markets Have Fear, the Sahm Rule is Here

Weekly Archive

Finn McGinnis | 07/30/24

Opportunity Equity Weekly Update for 7/19/2024 – 7/26/2024

Everi Jumps on Acquisition Announcement while General Motors Reports Strong Earnings

Weekly Archive

Finn McGinnis | 07/23/24

Opportunity Equity Weekly Update for 7/12/2024 – 7/19/2024

Western Alliance Jumps on Strong Q2 Print while Amazon Hosts a Record-Breaking Prime Day

News

| 07/19/24

Samantha McLemore on CNBC's 'The Exchange'

Watch Samantha McLemore on CNBC's 'The Exchange'

Weekly Archive

Finn McGinnis | 07/16/24

Opportunity Equity Weekly Update for 7/5/2024 – 7/12/2024

Expedia Rises on Increased Web Traffic while Delta Falls on Narrow Earnings Miss

Samantha McLemore's Quarterly Letter

Samantha McLemore | 07/11/24

“It was the best of times, it was the worst of times…”

Samantha McLemore discusses the second quarter of 2024, and her views moving forward.

Portfolio Activity and Attribution

Christina Siegel Malbon | 07/10/24

2Q24 Portfolio Activity and Attribution

Christina Malbon, CFA reviews the strategy and changes in the second quarter of 2024.

Weekly Archive

Finn McGinnis | 07/09/24

Opportunity Equity Strategy Update for 6/28/2024 - 7/5/2024

Tech Names Reach All-Time Highs while OneMain Falls on Weakening Branch Traffic

Weekly Archive

Finn McGinnis | 07/03/24

Opportunity Equity Weekly Update for 6/21/2024 – 6/28/2024

Energy Names Followed Crude Prices Higher while General Motors Announced Two Executive Changes

Quarterly Market Review

Christina Siegel Malbon | 07/03/24

Quarterly Market Review 2Q 2024

Christina Malbon, CFA Discusses the market highlights of the second quarter of 2024

Weekly Archive

Finn McGinnis | 06/24/24

Opportunity Equity Weekly Update for 6/14/2024 – 6/21/2024

Energy Transfer Follows Crude Higher while Coinbase Follows Bitcoin Lower

Weekly Archive

Finn McGinnis | 06/18/24

Opportunity Equity Strategy Update for 6/7/2024 - 6/14/2024

General Motors Rises on Buyback Authorization while OneMain Falls on Elevated Delinquencies

Weekly Archive

Finn McGinnis | 06/11/24

Opportunity Equity Weekly Update for 5/31/2024 – 6/7/2024

Precigen Jumps on Clinical Results while Energy Names Follow Crude Prices Lower

Weekly Archive

Finn McGinnis | 06/04/24

Opportunity Equity Strategy Update for 5/24/2024 - 5/31/2024

UBS Rises on Merger Completion while Coinbase Follows Bitcoin Lower

Weekly Archive

Finn McGinnis | 05/29/24

Opportunity Equity Weekly Update for 5/17/2024 – 5/24/2024

Nvidia Jumps on Strong Earnings While Peloton Falls on Debt Refinancing

News

Christina Siegel Malbon | 05/23/24

Christina Malbon on “Engaging Alternatives Spotlight

Christina Malbon joined Elana Margulies-Snyderman, on the “Engaging Alternatives Spotlight” podcast to share her outlook for value investing, its opportunities and challenges.

Weekly Archive

Finn McGinnis | 05/20/24

Opportunity Equity Weekly Update for 5/10/2024 – 5/17/2024

Canada Goose Jumps on Strong Fiscal Q4 Earnings While Amazon Falls on AWS Leadership Transition

Weekly Archive

Finn McGinnis | 05/15/24

Opportunity Equity Weekly Update for 5/3/2024 – 5/10/2024

Crocs Jumps on Strong Q1 Print While Coinbase Follows Bitcoin Lower

Weekly Archive

Finn McGinnis | 05/07/24

Opportunity Equity Weekly Update for 4/26/2024 – 5/3/2024

Amazon Rises on Record Profitability while Expedia Falls on Lower Guidance

Weekly Archive

Finn McGinnis | 04/30/24

Opportunity Equity Weekly Update for 4/19/2024 – 4/26/2024

Alphabet Inc. Reaches a New All-Time High after Announcing Earnings while Meta Falls on Increased CAPEX Guidance

Weekly Archive

Finn McGinnis | 04/23/24

Opportunity Equity Weekly Update for 4/12/2024 – 4/19/2024

United Airlines Rises on Strong Earnings while Coinbase Follows Bitcoin Lower

Hidden

| 04/18/24

PP,LP Quarterly Letter

PP,LP Quarterly Letter

Hidden

| 04/18/24

PP, LP QIR

PP, LP QIR

Hidden

| 04/18/24

PP, LP Fact Sheet

PP, LP Fact Sheet

Weekly Archive

Finn McGinnis | 04/16/24

Opportunity Equity Weekly Update for 4/5/2024 – 4/12/2024

Alphabet Reaches an All-Time High on Chip Announcement while UBS falls on Swiss Banking Reform

Samantha McLemore's Quarterly Letter

Samantha McLemore | 04/11/24

A Differentiated View on Diversification

Samantha McLemore discusses the first quarter of 2024, and her views moving forward.

Investor Insights

| 04/10/24

We wanted to share a letter from Dr. George Athanassakos

Portfolio Activity and Attribution

Christina Siegel Malbon | 04/10/24

1Q24 Portfolio Activity and Attribution

Christina Malbon, CFA reviews the strategy and changes in the first quarter of 2024.

Weekly Archive

William Keenan | 04/08/24

Opportunity Equity Weekly Update for 3/28/2024 – 4/5/2024

UBS Rises on Share Repurchase while United Falls on Delayed Investor Day

Investor Insights

Samantha McLemore | 04/05/24

Short Take: Mag 7 Expectations More Substance Than Hype

these are some of the best businesses ever created. Market expectations seem reasonable in aggregate.

Quarterly Market Review

Christina Siegel Malbon | 04/03/24

Quarterly Market Review 1Q 2024

Christina Malbon, CFA Discusses the market highlights of the first quarter of 2024

Weekly Archive

William Keenan | 04/02/24

Opportunity Equity Weekly Update for 3/22/2024 – 3/28/2024

S4 Rises on Takeover Interest while Meta Falls on Limited News

Weekly Archive

William Keenan | 03/25/24

Opportunity Equity Weekly Update for 3/15/2024 – 3/22/2024

Alphabet Rises on AI iPhone Integration while Precigen Falls on Downgrade

Weekly Archive

William Keenan | 03/19/24

Opportunity Equity Weekly Update for 3/8/2024 – 3/15/2024

Alphabet Rises on Autonomous Driving Unit while Coinbase Follows Bitcoin Prices Lower

News

| 03/13/24

Samantha McLemore on 'The Pomp Podcast"

Samantha McLemore went on ‘The Pomp Podcast’ and shared valuable insights into investing, emphasizing the importance of understanding business fundamentals and market dynamics.

News

| 03/11/24

Christina Malbon's CNBC Debut

Watch Christina Malbon's CNBC Debut

Weekly Archive

William Keenan | 03/11/24

Opportunity Equity Weekly Update for 3/1/2024 – 3/8/2024

Seadrill Rises on Earnings while SoFi Declines on Capital Raise

Weekly Archive

William Keenan | 03/05/24

Opportunity Equity Weekly Update for 2/23/2024 – 3/1/2024

Norwegian Rises on Earnings while Green Thumb Declines on Earnings

Investor Insights

Samantha McLemore | 03/01/24

The Power of Patience: Evidence Suggests Continued Market Gains

Good news from our friends at Birinyi Research.

Weekly Archive

William Keenan | 02/23/24

Opportunity Equity Weekly Update for 2/16/2024 – 2/23/2024

Travel + Leisure Rises on Earnings while Coinbase Follows Bitcoin Prices Lower

Weekly Archive

William Keenan | 02/20/24

Opportunity Equity Strategy Update for 2/9/2024 - 2/16/2024

Coinbase Rises on Earnings while Seadrill Declines on Limited News

Weekly Archive

William Keenan | 02/13/24

Opportunity Equity Weekly Update for 2/2/2024 – 2/9/2024

Coinbase Follows Bitcoin Prices Higher while Expedia Falls on Surprise CEO Transition

Weekly Archive

William Keenan | 02/06/24

Opportunity Equity Weekly Update for 1/26/2024 – 2/2/2024

Meta Rises on Earnings while Peloton Declines on Earnings

Investor Insights

Christina Siegel Malbon | 02/06/24

Is now the time for Small-Cap Outperformance?

Given small-caps’ significant recent underperformance, many are enthusiastic about their potential to outperform in the future. Is this an easy mean reversion call? Not so fast.

Weekly Archive

William Keenan | 01/29/24

Opportunity Equity Strategy Update for 1/19/2024 - 1/26/2024

United Airlines Rises on Earnings while Kosmos Declines Despite Rising Commodity Prices

Weekly Archive

William Keenan | 01/22/24

Opportunity Equity Weekly Update for 1/12/2024 – 1/19/2024

Western Alliance Rises on Earnings Anticipation while OneMain Declines on ABS Deterioration

Weekly Archive

William Keenan | 01/17/24

Opportunity Equity Weekly Update for 1/5/2024 – 1/12/2024

Crocs Rises on Earnings Pre-Announcement while Delta Declines on Earnings

Hidden

| 01/17/24

Patient Strategy Composite Disclosures

Patient Strategy Composite Disclosures

Samantha McLemore's Quarterly Letter

Samantha McLemore | 01/17/24

"The big money is not in the buying and selling, but in the waiting.” - Charlie Munger

Samantha McLemore discusses the current environment and how we are responding. We also reflect on 2023: what we’ve done well and where we made mistakes

Portfolio Activity and Attribution

Christina Siegel Malbon | 01/17/24

4Q23 Portfolio Activity and Attribution

Christina Malbon, CFA reviews the strategy and changes in the final quarter of 2023.

Investor Insights

Samantha McLemore | 01/09/24

A Generational Buying Opportunity in Classic Value

We believe low multiple stocks (“classic value”) offer a generational buying opportunity.

Weekly Archive

William Keenan | 01/08/24

Opportunity Equity Weekly Update for 12/29/2023 – 1/5/2024

Citi Rises on Wells Fargo Upgrade while SoFi Declines on KBW Downgrade

Weekly Archive

William Keenan | 01/03/24

Opportunity Equity Weekly Update for 12/22/2023 – 12/29/2023

PureTech Continues to Rise on Karuna Acquisition while Travel Names Decline on Limited News

Quarterly Market Review

Christina Siegel Malbon | 01/02/24

Quarterly Market Review 4Q 2023

Christina Siegel Malbon, CFA, Assistant Portfolio Manager, summarizes the drivers of the market’s positive return for the final quarter of 2023.

Weekly Archive

William Keenan | 12/27/23

Opportunity Equity Strategy Update for 12/15/2023 - 12/22/2023

Karuna Rises on Acquisition by Bristol Myers while Airlines Decline on Limited News

Weekly Archive

William Keenan | 12/19/23

Opportunity Equity Weekly Update for 12/8/2023 – 12/15/2023

Delta Continues to Rise on Strong Travel Outlook while Alphabet Falls on Epic Games Antitrust Ruling

News

| 12/14/23

Samantha McLemore on CNBC's Closing Bell: Overtime

Samantha McLemore joined Closing Bell: Overtime to discuss the current market enviornment.

Time, Not Timing Stories

| 12/14/23

Geoffrey Holt Amassed a Fortune Through Consistent, Patient Investing

We love stories about people who amass fortunes through the simple principles of living below their means and long term investing that enables the magic of compounding.

Weekly Archive

William Keenan | 12/11/23

Opportunity Equity Weekly Update for 12/1/2023 – 12/8/2023

Delta Rises on Guidance Affirmation while Energy Names follow Commodity Prices Lower

Weekly Archive

William Keenan | 12/04/23

Opportunity Equity Strategy Update for 11/24/2023 - 12/1/2023

General Motors Rises on Guidance Reinstatement while Alibaba Continues to Decline on Change in Strategy

Weekly Archive

William Keenan | 11/27/23

Opportunity Equity Strategy Update for 11/17/2023 - 11/24/2023

Karuna Rises on Positive Phase 1b Trial Data while Peloton Falls on Thanksgiving “Turkey Burn” Outage

Weekly Archive

William Keenan | 11/20/23

Opportunity Equity Weekly Update for 11/10/2023 – 11/17/2023

Expedia Rises on Reported ValueAct Stake while Alibaba Declines on Spinoff Reversal

Weekly Archive

William Keenan | 11/14/23

Opportunity Equity Weekly Update for 11/3/2023 – 11/10/2023

Amazon and Meta Rise on New Deal while General Motors Falls on Cruise Unit Concerns

Weekly Archive

William Keenan | 11/07/23

Opportunity Equity Weekly Update for 10/27/2023 – 11/3/2023

Expedia Rises on Earnings while Canada Goose Declines on Lowered Guidance

Investor Insights

Christina Siegel Malbon, Samantha McLemore | 10/31/23

Trailing Returns Signal Buying Opportunity

“Buy low, sell high” may sound easy, but implementing that strategy is anything but natural. The recent sell-off has triggered a buy signal that’s historically worked very well.

Weekly Archive

William Keenan | 10/30/23

Opportunity Equity Weekly Update for 10/20/2023 – 10/27/2023

Capital One Rises on Earnings while Alphabet Declines on Disappointing Cloud Revenue

Weekly Archive

William Keenan | 10/23/23

Opportunity Equity Strategy Update for 10/13/2023 - 10/20/2023

Energy Transfer Follows Energy Higher while United Falls Despite Strong Earnings

Weekly Archive

William Keenan | 10/16/23

Opportunity Equity Weekly Update for 10/6/2023 – 10/13/2023

Citigroup Rises on Earnings while Transports Fall on Rising Oil Prices

Samantha McLemore's Quarterly Letter

Samantha McLemore | 10/11/23

On Expectations: Low, Low, Low, Low, Low, Low, Low, Low

Opportunity Equity 3Q23 Commentary

Portfolio Activity and Attribution

Christina Siegel Malbon | 10/11/23

3Q23 Portfolio Activity and Attribution

Christina Malbon, CFA reviews the strategy and changes in the third quarter of 2023.

What We are Reading

| 10/10/23

Reading List - Fall 2023

Check out what the Patient Capital team has been reading

Weekly Archive

William Keenan | 10/09/23

Opportunity Equity Weekly Update for 9/29/2023 – 10/6/2023

Alphabet Rises on AI-enabled Device Launch while GM Falls on Strike Concessions

Quarterly Market Review

Christina Siegel Malbon | 10/05/23

Quarterly Market Review 3Q 2023

Christina Malbon, CFA Discusses the market highlights of the third quarter of 2023.

Weekly Archive

William Keenan | 10/03/23

Opportunity Equity Weekly Update for 9/22/2023 – 9/29/2023

Peloton Rises on lululemon Partnership while Amazon Falls on FTC Suit

News

| 09/29/23

Samantha McLemore Debuts on CNBC

Watch Samantha McLemore's TV Debut on CNBC's The Exchange with Kelly Evans

Weekly Archive

William Keenan | 09/25/23

Opportunity Equity Strategy Update for 9/15/2023 - 9/22/2023

Splunk Rises on Cisco Acquisition while S4 Capital Falls on Earnings

Weekly Archive

William Keenan | 09/18/23

Opportunity Equity Strategy Update for 9/8/2023 - 9/15/2023

Citi Rises on Corporate Reorganization while United Falls with Broader Sector

Weekly Archive

William Keenan | 09/11/23

Opportunity Equity Weekly Update for 9/1/2023 – 9/8/2023

Green Thumb Rises on Repurchase Announcement while on Peloton Falls on Bike Lawsuit

Weekly Archive

William Keenan | 09/05/23

Opportunity Equity Weekly Update for 8/25/2023 – 9/1/2023

UBS Rises on Earnings while Green Thumb Rises on HHS Recommendation

Weekly Archive

William Keenan | 08/28/23

Opportunity Equity Weekly Update for 8/18/2023 – 8/25/2023

Splunk Rises on Earnings while Peloton Falls on Earnings

Weekly Archive

William Keenan | 08/22/23

Opportunity Equity Strategy Update for 8/11/2023 - 8/18/2023

Energy Transfer Rises on Crestwood Acquisition while Farfetch Falls on Earnings

Investor Insights

Tyler Grason | 08/18/23

Are Copper Stocks Attractive?

We recently did some work on copper stocks to determine whether we believe an investment opportunity exists.

Weekly Archive

William Keenan | 08/14/23

Opportunity Equity Weekly Update for 8/4/2023 – 8/11/2023

Precigen Rises on FDA Approval while IAC Falls on Earnings

Weekly Archive

William Keenan | 08/08/23

Opportunity Equity Weekly Update for 7/28/2023 – 8/4/2023

Amazon Rises on Earnings while Expedia Falls on Earnings

Weekly Archive

William Keenan | 07/31/23

Opportunity Equity Strategy Update for 7/21/2023 - 7/28/2023

Alphabet and Meta Rise on Earnings while S4 Declines on Lowered Guidance

Weekly Archive

William Keenan | 07/25/23

Opportunity Equity Weekly Update for 7/14/2023 – 7/21/2023

United and Western Alliance Rise on Earnings while Farfetch Declines on Limited News

Portfolio Activity and Attribution

Christina Siegel Malbon | 07/21/23

2Q23 Opportunity Equity Portfolio Activity and Attribution

Christina Malbon, CFA reviews the strategy and changes in the second quarter of 2023.

Weekly Archive

William Keenan | 07/18/23

Opportunity Equity Weekly Update for 7/7/2023 – 7/14/2023

Coinbase Rises on District Court Ruling while Delta Falls Despite Strong 2Q Earnings

Investor Insights

Christina Siegel Malbon | 07/18/23

Could Much Higher Valuations be Justified?

We wanted to share a noteworthy piece of research discussing a scenario warranting much higher asset valuations.

Samantha McLemore's Quarterly Letter

Samantha McLemore | 07/14/23

On Growth and Change

Samantha McLemore discusses the second quarter of 2023, and her views moving forward.

Weekly Archive

William Keenan | 07/10/23

Opportunity Equity Strategy Update for 6/30/2023 - 7/7/2023

Alibaba Rises on Ant Fine while SoFi Falls Despite Supreme Court Decision

Investor Insights

Samantha McLemore | 07/06/23

Good News! History Suggests Continued Market Gains

Samantha McLemore discusses historic forward returns after a bear market, and how there could be reason for optimism.

Weekly Archive

William Keenan | 07/05/23

Opportunity Equity Weekly Update for 6/23/2023 – 6/30/2023

Coinbase Rises on Bitcoin ETF Prospectuses while Alibaba Continues to Fall

Quarterly Market Review

Christina Siegel Malbon | 07/05/23

Quarterly Market Review 2Q 2023

Christina Malbon, CFA Discusses the market highlights of the second quarter of 2023.

Weekly Archive

William Keenan | 06/27/23

Opportunity Equity Weekly Update for 6/16/2023 – 6/23/2023

Coinbase Rises on Supreme Court Ruling while Alibaba Falls on Management Shakeup

Weekly Archive

William Keenan | 06/21/23

Opportunity Equity Weekly Update for 6/9/2023 – 6/16/2023

Delta Rises on Quarterly Dividend Resumption while Farfetch Falls Despite Logistics Partnership

Hidden

| 06/08/23

Time, Not Timing

At Patient Capital we have an adage often repeated around the office that “time, not timing is key to long term investment success.”

Weekly Archive

William Keenan | 06/05/23

Opportunity Equity Weekly Update for 5/26/2023 – 6/2/2023

SoFi Rises on End of Student Loan Moratorium while Teva Declines on Rating Outlook Downgrade

Weekly Archive

William Keenan | 06/02/23

Opportunity Equity Strategy Update for 5/19/2023 - 5/26/2023

Meta Rises on Continued Efficiency Gains while Canada Goose Continues Post-Earnings Decline

News

| 05/31/23

Patient Capital Finalizes Bill Miller’s Succession Planning Deal

Patient Capital Management, LLC (“Patient Capital”) announced it has completed the acquisition of the Opportunity Equity business from Miller Value Partners (“Miller Value”) as part of legendary investor Bill Miller’s previously announced succession plans.

Hidden

| 05/26/23

Time, Not Timing

A janitor from Vermont. A secretary. A flutist. A woman actively discriminated against who never made more than $3,150 per year. Every day people have amassed millions by practicing a simple principle. Buying stocks and holding them. Investment success is simple but not easy. Long term compounding works wonders. Practice Time, Not Timing.

Portfolio Activity and Attribution

Christina Siegel Malbon | 04/20/23

1Q23 Portfolio Activity and Attribution

Christina Malbon, CFA reviews the strategy and changes in the first quarter of 2023.

Samantha McLemore's Quarterly Letter

Samantha McLemore | 04/18/23

Forget Market Forecasts. Trust A Strong Investment Process.

We ended another surprise-filled quarter, which really should be no surprise at all. The future is unpredictable.

Weekly Archive

William Keenan | 04/11/23

Opportunity Equity Update for Week Ended 4/7/23

Ovintiv Gains on Permian Acquisition while Expedia Falls Despite Chat-GPT Rollout

Quarterly Market Review

Christina Siegel Malbon | 04/10/23

Quarterly Market Review 1Q 2023

Equities and bonds are off to a good start in 2023. Christy Siegel, CFA summarizes the market’s return drivers in Q1 2023 and the impact as a whole on the year

Weekly Archive

William Keenan | 04/04/23

Opportunity Equity Update for Week Ended 3/31/23

Alibaba Gains on Six Part Split while S4 Capital Falls on Underwhelming Revenue Guidance

Weekly Archive

William Keenan | 03/28/23

Opportunity Equity Update for Week Ended 3/24/23

Meta Gains on Potential TikTok Ban while Travel Names Continue to be Under Pressure on Recession Fears

Investor Insights

Samantha McLemore | 03/22/23

The S&P 500 Remains Far Below Its Highs. Historically That Is a Buy Signal

While the S&P 500 remains below its highs, this might be presenting a good buying opportunity. Samantha McLemore discusses how historically the data suggests buying now might be a good strategy in the long term.

Weekly Archive

William Keenan | 03/21/23

Opportunity Equity Update for Week Ended 3/17/23

Coinbase Follows Bitcoin Prices Higher while Travel Names Fall on Fears of Recession

Weekly Archive

William Keenan | 03/14/23

Opportunity Equity Update for Week Ended 3/10/23

Alaunos Remains Roughly Flat on 4Q Results while OneMain Falls on Fears of Broader Financial Sector Contagion

Weekly Archive

William Keenan | 03/07/23

Opportunity Equity Update for Week Ended 3/3/23

Cleveland-Cliffs Rises on Price Hike and Credit Rating Upgrade While Silvergate Falls on Delayed Form 10-K Filing

Weekly Archive

William Keenan | 02/28/23

Opportunity Equity Update for Week Ended 2/24/23

Farfetch Rises on Earnings While Coinbase Falls on Earnings Miss

Weekly Archive

William Keenan | 02/22/23

Opportunity Equity Update for Week Ended 2/17/23

Silvergate and Coinbase Follow Bitcoin Prices Higher While Ovintiv Follows Commodity Prices Lower

Weekly Archive

William Keenan | 02/14/23

Opportunity Equity Update for Week Ended 2/10/23

Uber Rises on Robust Profitability Outlook While Mattel Falls on Earnings Miss

Weekly Archive

William Keenan | 02/07/23

Opportunity Equity Update for Week Ended 2/3/23

Meta Rises on Improved Expense Outlook While Canada Goose Falls on Earnings Miss

Weekly Archive

William Keenan | 01/31/23

Opportunity Equity Update for Week Ended 1/27/23

Capital One Rises on Solid Results While Precigen Falls on Equity Offering Following Positive Phase 1 Trial Results

Investor Insights

Christina Siegel Malbon | 01/30/23

Bearish or Bullish, That is the Question

Siegel and McLemore on today’s market and reasons to be more bullish in the new year.

Portfolio Activity and Attribution

Christina Siegel Malbon | 01/27/23

4Q22 Opportunity Equity Portfolio Activity and Attribution

Christina Siegel, CFA Research Analyst reviews the fourth quarter of 2022.

Weekly Archive

William Keenan | 01/24/23

Opportunity Equity Update for Week Ended 1/20/23

Google Rises on Headcount Reduction While United Falls Despite Strong Earnings and Outlook

Weekly Archive

William Keenan | 01/18/23

Opportunity Equity Update for Week Ended 1/13/23

United Rises on Strong Delta Earnings While Green Thumb Falls Despite Recreational Rollout in Connecticut

Samantha McLemore's Quarterly Letter

Samantha McLemore | 01/13/23

“Every new beginning comes from some other beginning’s end.”

Samantha McLemore, portfolio manager of the Opportunity Equity strategy, on today’s market and positioning for a long term portfolio.

Quarterly Market Review

Christina Siegel Malbon | 01/10/23

Quarterly Market Review 4Q 2022

With both major stock and bond indexes ending in the year in red. Christy Siegel, CFA summarizes the market’s return drivers in Q4 2022 and the impact as a whole on the year.

Weekly Archive

William Keenan | 01/10/23

Opportunity Equity Update for Week Ended 1/6/23

Alibaba Gains on Ant Group Regulatory Approval While Silvergate Falls on Worse than Expected 4Q 2022 Results

Weekly Archive

William Keenan | 01/04/23

Opportunity Equity Update for Week Ended 12/30/22

Alibaba and Farfetch Gains on China Reopening While Norwegian Continues Decline on Disappointing Carnival Earnings and Negative Court Ruling

Weekly Archive

William Keenan | 12/28/22

Opportunity Equity Update for Week Ended 12/23/22

Cleveland-Cliffs Gains on Pricing Increases While Norwegian Declines on Disappointing Carnival Earnings

Weekly Archive

William Keenan | 12/20/22

Opportunity Equity Update for Week Ended 12/16/22

SoFi Gains on Large Insider Purchase While Green Thumb Continues to Decline on Delayed SAFE Banking Legislation

Weekly Archive

William Keenan | 12/13/22

Opportunity Equity Update for Week Ended 12/9/22

Stitch Fix Gains on Bottom-Line Beat While Green Thumb Declines on Delayed SAFE Banking Legislation

Weekly Archive

William Keenan | 12/06/22

Opportunity Equity Update for Week Ended 12/2/22

Alibaba Gains on Moderating Zero-COVID Policies While Farfetch Declines on Disappointing Capital Markets Day Guidance

Weekly Archive

William Keenan | 11/29/22

Opportunity Equity Update for Week Ended 11/25/22

Silvergate Gains on Block.one Stakes While SoFi Falls on Senate Banking Committee Inquiry and Student Loan Moratorium Extension

Weekly Archive

William Keenan | 11/22/22

Opportunity Equity Update for Week Ended 11/18/22

Alibaba Gains on Earnings and Updated Zero-COVID Policy While Silvergate Continues to Fall Following FTX Bankruptcy

Weekly Archive

Christina Siegel Malbon | 11/15/22

Opportunity Equity Update for Week Ended 11/11/22

Farfetch Gains on Moderating Inflation and Updated Zero-COVID Policy While Cryptocurrency Names Fall in Sympathy with FTX Bankruptcy

Weekly Archive

Christina Siegel Malbon | 11/08/22

Opportunity Equity Update for Week Ended 11/4/22

Energy Names Follow Commodity Prices Higher While Teva fell on 3Q Earnings

Weekly Archive

Christina Siegel Malbon | 11/01/22

Opportunity Equity Update for Week Ended 10/28/22

OneMain Rises on Strong Earnings while Meta Falls on Earnings and Higher-than-Expected Expense Outlook

Weekly Archive

Christina Siegel Malbon | 10/24/22

Opportunity Equity Update for Week Ended 10/21/22

United Rises on Strong Earnings while Silvergate Falls on Lower Deposits

Portfolio Activity and Attribution

Christina Siegel Malbon | 10/21/22

3Q22 Opportunity Equity Portfolio Activity and Attribution

Christina Siegel, CFA Research Analyst reviews the third quarter of 2022.

Samantha McLemore's Quarterly Letter

Samantha McLemore | 10/18/22

Opportunity Equity 3Q2022 Commentary

Samantha McLemore, portfolio manager of the Opportunity Equity Strategy, on today’s market and positioning for a long term portfolio.

Weekly Archive

Christina Siegel Malbon | 10/17/22

Opportunity Equity Update for Week Ended 10/14/22

Delta Rises on Solid Earnings while Uber Falls on Renewed Gig Worker Scrutiny

Weekly Archive

Christina Siegel Malbon | 10/10/22

Opportunity Equity Update for Week Ended 10/7/22

Ovintiv and Diamondback Energy Gain on OPEC Production Cuts While PureTech Falls on Merger Talks

Quarterly Market Review

Christina Siegel Malbon | 10/07/22

Quarterly Market Review 3Q 2022

With both major stock and bond indexes ending in the red, the markets continue to struggle through Q3 2022. Christy Siegel, CFA summarizes the market’s return drivers.

Weekly Archive

Christina Siegel Malbon | 10/04/22

Opportunity Equity Update for Week Ended 9/30/22

Ovintiv Follows Commodity Prices Higher While NCLH Falls in Sympathy with Carnival

Investor Insights

Tyler Grason | 09/29/22

Back to the 1970s? Reflections & Takeaways for Positioning in Today's Market

Tyler Grason reflects on market worries on inflation and provides positions for today’s market.

Weekly Archive

Christina Siegel Malbon | 09/26/22

Opportunity Equity Update for Week Ended 9/23/22

Bausch Falls on Xifaxan Concerns While Ovintiv and Energy Transfer Follow Commodity Prices Lower

Weekly Archive

Christina Siegel Malbon | 09/19/22

Opportunity Equity Update for Week Ended 9/16/22

Uber Rises on CEO Presentation While Cleveland-Cliffs Followed Steel Prices Lower

Weekly Archive

Christina Siegel Malbon | 09/12/22

Opportunity Equity Update for Week Ended 9/9/22

ADT Rises on State Farm Investment While DXC Technology Falls on Limited News

Weekly Archive

Christina Siegel Malbon | 09/06/22

Opportunity Equity Update for Week Ended 9/2/22

Bausch Health Rises on Exchange Offer while Cleveland-Cliffs Follows Commodity Prices Lower

Weekly Archive

Christina Siegel Malbon | 08/30/22

Opportunity Equity Update for Week Ended 8/26/22

Farfetch Rises on Richemont Deal while Splunk Falls on Guidance

Weekly Archive

Christina Siegel Malbon | 08/23/22

Opportunity Equity Update for Week Ended 8/19/22

GM Rises on Resumption of Dividend and Buybacks While Teva Falls on Zantac Litigation

Weekly Archive

Christina Siegel Malbon | 08/15/22

Opportunity Equity Update for Week Ended 8/12/22

Karuna Rises on Positive KarXT Phase 3 Trial Results While Vontier Falls on CFO Transition

Weekly Archive

Christina Siegel Malbon | 08/08/22

Opportunity Equity Update for Week Ended 8/5/22

Uber Rises on Earnings While DXC Falls on Foreign Exchange Headwinds

Weekly Archive

Christina Siegel Malbon | 08/02/22

Opportunity Equity Update for Week Ended 7/29/22

Teva Rises on Opioid Litigation Settlement While Bausch Falls on Unfavorable Xifaxan Ruling

Weekly Archive

Christina Siegel Malbon | 07/26/22

Opportunity Equity Update for Week Ended 7/22/22

Amazon Gains on One Medical Acquisition While Alphabet Falls in Sympathy with Snap Earnings

Portfolio Activity and Attribution

Christina Siegel Malbon | 07/19/22

2Q22 Opportunity Equity Portfolio Activity and Attribution

Christina Siegel, CFA Research Analyst reviews the second quarter of 2022.

Weekly Archive

Christina Siegel Malbon | 07/18/22

Opportunity Equity Update for Week Ended 7/15/22

Citi Gains on Earnings While Alibaba Falls on Renewed Regulatory Concerns

Samantha McLemore's Quarterly Letter

Samantha McLemore | 07/15/22

Extreme Times: A Once in a Decade Opportunity?

After the S&P 500 posted its worst first half loss in over 50 years, Samantha McLemore discusses the extremes we have seen in the market in her 2Q letter. She discusses historical analogs for this period and explains how she believes the portfolio is positioned for significant upside potential if we're patient.

Weekly Archive

Christina Siegel Malbon | 07/11/22

Opportunity Equity Update for Week Ended 7/8/22

Splunk Gains on New Buy Rating While Energy Names Follow Commodity Prices Lower

Quarterly Market Review

Christina Siegel Malbon | 07/08/22

Quarterly Market Review 2Q 2022

The markets still struggled in the second quarter with both major stock and bond indexes ending in the red. Christy Siegel, CFA summarizes the market’s return drivers.

Weekly Archive

Christina Siegel Malbon | 07/05/22

Opportunity Equity Update for Week Ended 7/1/22

Taylor Morrison Gained as Interest Rates Moved Lower While Farfetch Fell on Price Target Reductions

Investor Insights

Samantha McLemore | 07/01/22

Plea(sing) For the Long Term

McLemore discusses potential of long term rewards from market lows.

Weekly Archive

Christina Siegel Malbon | 06/27/22

Opportunity Equity Update for Week Ended 6/24/22

Alibaba Gains on Improved China Outlook While Diamondback Follows Commodities Lower Despite Increased Capital Return Program

News

Bill Miller | 06/27/22

Bill Miller’s Interview with Richer, Wiser, Happier Podcast Host William Green

Bill Miller’s Interview with Richer, Wiser, Happier Podcast Host William Green

Weekly Archive

Christina Siegel Malbon | 06/21/22

Opportunity Equity Update for Week Ended 6/17/22

TLT Puts Move Higher with Rates While Energy Names Fall on Lower Commodity Prices

Weekly Archive

Christina Siegel Malbon | 06/13/22

Opportunity Equity Update for Week Ended 6/10/22

Alibaba Gains on Potential Regulatory Easing while Norwegian Falls on Price Target Decreases

Weekly Archive

Christina Siegel Malbon | 06/06/22

Opportunity Equity Update for Week Ended 6/3/22

Amazon Gains on Anticipation of Stock Split While United, Delta Drop on Higher Fuel Concerns

Weekly Archive

Christina Siegel Malbon | 05/31/22

Opportunity Equity Update for Week Ended 5/27/22

Ovintiv, Diamondback Rise in Sympathy with Crude Prices While Bausch Health, Tupperware Drop on Price Target Cuts

Weekly Archive

Christina Siegel Malbon | 05/24/22

Opportunity Equity Update for Week Ended 5/20/22

Teva Gains on Upgrade While Norwegian Falls on Price Target Cut

Weekly Archive

Christina Siegel Malbon | 05/17/22

Opportunity Equity Update for Week Ended 5/13/22

Taylor Morrison Gains on Rate Pullback While Ovintiv Falls on Earnings Release

Weekly Archive

Christina Siegel Malbon | 05/10/22

Opportunity Equity Update for Week Ended 5/6/22

Energy Names Rise on Higher Crude Prices while Tupperware Falls on Earnings

Weekly Archive

Christina Siegel Malbon | 05/03/22

Opportunity Equity Update for Week Ended 4/29/22

Alibaba Climbs as Government Calls for Normalization of Regulation While Amazon Falls on Cost Deleverage

Portfolio Activity and Attribution

Christina Siegel Malbon | 04/29/22

1Q22 Opportunity Equity Portfolio Activity and Attribution

Christina Siegel, CFA Research Analyst reviews the first quarter of 2022.

Samantha McLemore's Quarterly Letter

Samantha McLemore | 04/29/22

Exploiting Volatility to Outmaneuver the Market

Opportunity Equity 1Q22 Letter: Samantha McLemore on the buying opportunities in today’s market and portfolio positioning for a long cycle market shift.

Weekly Archive

Christina Siegel Malbon | 04/26/22

Opportunity Equity Update for Week Ended 4/22/22

Delta Gains on Earnings Momentum While Teva Falls on FDA Ruling

Weekly Archive

Christina Siegel Malbon | 04/19/22

Opportunity Equity Update for Week Ended 4/14/22

Delta Gains on Lower Loss While Alphabet Falls on Higher CapEx Guidance

Weekly Archive

Christina Siegel Malbon | 04/11/22

Opportunity Equity Update for Week Ended 4/8/22

Teva Gains on Barclays Upgrade While Amazon Falls on Warehouse Unionization

Quarterly Market Review

Christina Siegel Malbon | 04/07/22

Quarterly Market Review 1Q 2022

The market struggled in the first quarter with both major stock and bond indexes ending in the red. Christy Siegel, CFA summarizes the market’s return drivers.

Weekly Archive

Christina Siegel Malbon | 04/04/22

Opportunity Equity Update for Week Ended 4/1/22

Norwegian Gains on Positive Initiation While Taylor Morrison Falls on Downgrade

Weekly Archive

Christina Siegel Malbon | 03/28/22

Opportunity Equity Update for Week Ended 3/25/22

Diamondback and Ovintiv Gain on Higher Energy Prices While Taylor Morrison Falls on Higher Interest Rates

Bill Miller's Historical Letters

Bill Miller | 03/22/22

Bill Miller’s Market Perspective: March 2022

Bill Miller on today's market conditions, answering the question where are today's value opportunities?

Weekly Archive

Christina Siegel Malbon | 03/21/22

Opportunity Equity Update for Week Ended 3/18/22

JD and Alibaba Rebound on Positive Government Commentary While ET Falls with Energy Prices

Weekly Archive

Christina Siegel Malbon | 03/14/22

Opportunity Equity Update for Week Ended 3/11/22

Weekly Archive

Christina Siegel Malbon | 03/07/22

Opportunity Equity Update for Week Ended 3/4/22

Tupperware Gains on Accelerated Share Repurchase While DXC Falls on Russia/Ukraine Exposure

Weekly Archive

Christina Siegel Malbon | 02/28/22

Opportunity Equity Update for Week Ended 2/25/22

Farfetch Gains on Strong Topline Growth While Herbalife Falls After Earnings Miss

Weekly Archive

Christina Siegel Malbon | 02/22/22

Opportunity Equity Update for Week Ended 2/18/22

Mattel Gains on Investor Day While Vontier Falls on EMV Revenue Headwinds

Weekly Archive

Christina Siegel Malbon | 02/14/22

Opportunity Equity Update for Week Ended 2/11/22

Mattel Gains on Strong FY22 Guidance While Canada Goose Falls on FY22 Guidance Reduction

Weekly Archive

Christina Siegel Malbon | 02/07/22

Opportunity Equity Update for Week Ended 2/4/22

DXC Gains on Free Cash Flow Beat While Meta Falls on Weaker Guidance

Weekly Archive

Christina Siegel Malbon | 01/31/22

Opportunity Equity Update for Week Ended 1/28/22

Diamondback Energy Rises on Higher Energy Prices While Alibaba Falls on Price Target Reductions

Weekly Archive

Christina Siegel Malbon | 01/25/22

Opportunity Equity Update for Week Ended 1/21/22

SoFi Rises on Bank Charter while Farfetch Falls on Multiple Price Target Reductions

Samantha McLemore's Quarterly Letter

Samantha McLemore | 01/21/22

Has the Great Growth Bull Taken Its Last Gasp?

Opportunity Equity 4Q 2021 Letter: The Market’s patience with perennial money losers seems to have run out. Samantha McLemore discusses macro factors and investor sentiment going into the new year.

Weekly Archive

Christina Siegel Malbon | 01/19/22

Opportunity Equity Update for Week Ended 1/14/22

Diamondback and Ovintiv Rise on Higher Fuel Prices while JP Morgan Falls on Higher Expense Guidance

Weekly Archive

Christina Siegel Malbon | 01/11/22

Opportunity Equity Update for Week Ended 1/7/22

Diamondback Rises on Higher Oil Prices While Taylor Morrison Falls on Higher Interest Rates

Quarterly Market Review

Christina Siegel Malbon | 01/10/22

Quarterly Market Review 4Q 2021

2021 ended on a strong note for all major indices despite ending on rising COVID uncertainty.

Weekly Archive

Christina Siegel Malbon | 01/03/22

Opportunity Equity Update for Week Ended 12/31/21

Green Thumb Rises on New Market Entry while NCLH Falls on CDC Recommendation

Weekly Archive

Christina Siegel Malbon | 12/21/21

Opportunity Equity Update for Week Ended 12/17/21

Uber Rises on CEO Commentary While GM Falls on Cruise CEO Departure

Weekly Archive

Christina Siegel Malbon | 12/14/21

Opportunity Equity Update for Week Ended 12/10/21

NCLH Rises After Omicron Fears Ease While Stitch Fix Falls After Disappointing Guidance

Weekly Archive

Christina Siegel Malbon | 12/07/21

Opportunity Equity Update for Week Ended 12/3/21

Taylor Morrison Rises on Higher-than-Expected Pending Home Sales While JD Falls on Broader Chinese Internet Selloff

Weekly Archive

Christina Siegel Malbon | 11/30/21

Opportunity Equity Update for Week Ended 11/26/21

Diamondback Gains on Price Target Increases While Norwegian Falls on Omicron Variant Fears

Weekly Archive

Christina Siegel Malbon | 11/22/21

Opportunity Equity Update for Week Ended 11/19/21

Matterport Gains on Increased Visibility while Farfetch Falls on Earnings

Weekly Archive

Christina Siegel Malbon | 11/15/21

Opportunity Equity Update for Week Ended 11/12/21

Green Thumb Gains on Strong Outlook while Norwegian Falls on Earnings

Weekly Archive

Christina Siegel Malbon | 11/09/21

Opportunity Equity Update for Week Ended 11/5/21

Canada Goose Gains on Strong Outlook while Tupperware Falls on Earnings

Weekly Archive

Christina Siegel Malbon | 11/01/21

Opportunity Equity Update for Week Ended 10/29/21

Matterport Gains on Wedbush Recommendation while Teva Falls on Earnings

Samantha McLemore's Quarterly Letter

Samantha McLemore | 10/26/21

Optimizing for Long-term Return Potential

Opportunity Equity 1Q 2021 Letter: Despite the strong market this quarter, there were key lessons to be learned.

Weekly Archive

Christina Siegel Malbon | 10/25/21

Opportunity Equity Update for Week Ended 10/22/21

Farfetch Gains on Richemont Speculation While OneMain Falls on Earnings

Bill Miller's Historical Letters

Bill Miller | 10/18/21

Bill Miller 3Q 2021 Market Letter

We believe time, not timing, is key to building wealth in the stock market.

Weekly Archive

Christina Siegel Malbon | 10/18/21

Opportunity Equity Update for Week Ended 10/15/21

Splunk Gained on Positive Report While Delta Fell on Disappointing 4Q Guidance

Quarterly Market Review

Christina Siegel Malbon | 10/13/21

Quarterly Market Review 3Q 2021

Macro concerns around the delta variant and China weighed on the market this quarter, producing mixed results.

Weekly Archive

Christina Siegel Malbon | 10/11/21

Opportunity Equity Update for Week Ended 10/8/21

Diamondback Energy Gains on Rising Commodities Prices While Facebook Falls on Whistleblower Testimony

Weekly Archive

Christina Siegel Malbon | 10/04/21

Opportunity Equity Update for Week Ended 10/1/21

Diamondback Energy and Energy Transfer Gain on Rising Commodities Prices While Matterport Falls Despite new Buy Rating

News

| 09/30/21

The Wisdom and Experience of Investing Greats

Bill Miller and William Green on the wisdom of great investors. Includes a reading list.

Weekly Archive

Christina Siegel Malbon | 09/27/21

Opportunity Equity Update for Week Ended 9/24/21

Uber Rises as Profitability Comes Sooner Than Expected, While Alibaba Falls on Fears Over Evergrande

Weekly Archive

Christina Siegel Malbon | 09/21/21

Opportunity Equity Update for Week Ended 9/17/21

Matterport Gains on Price Target Increase While Alibaba Falls on Continued Regulatory Pressure

Weekly Archive

Christina Siegel Malbon | 09/13/21

Opportunity Equity Update for Week Ended 9/10/21

Matterport Rises on Price Target Increase, Stitch Fix Falls on Negative Article

Weekly Archive

Christina Siegel Malbon | 09/07/21

Opportunity Equity Update for Week Ended 9/3/21

Matterport Rises on Expansion of Service Locations, While Capital One Falls on Downgrade

Weekly Archive

Christina Siegel Malbon | 08/30/21

Opportunity Equity Update for Week Ended 8/27/21

Norwegian Cruise Lines Rises on Vaccine Approval, While Grayscale Bitcoin Trust Falls as Bitcoin Momentum Slows

Weekly Archive

Christina Siegel Malbon | 08/26/21

Opportunity Equity Update for Week Ended 8/20/21

Grasyscale Gains on Bitcoin Rise, While DXC Falls on Downgrade

Weekly Archive

Christina Siegel Malbon | 08/16/21

Opportunity Equity Update for Week Ended 8/13/21

Rocket Rises on Strong Guidance, while WW International Falls on Earnings Miss

Weekly Archive

Christina Siegel Malbon | 08/09/21

Opportunity Equity Update for Week Ended 8/6/21

Tupperware Rises on Strong Results, While ADT Falls On Continued Growth Spend

Samantha McLemore's Quarterly Letter

Samantha McLemore | 08/03/21

Fundamentals v Expectations

Opportunity Equity 2Q 2021 Letter

Weekly Archive

Christina Siegel Malbon | 08/03/21

Opportunity Equity Update for Week Ended 7/30/21

Teva Rises on Settlement Optimism, While Amazon.com Falls on Revenue Miss.

Weekly Archive

Christina Siegel Malbon | 07/27/21

Opportunity Equity Update for Week Ended 7/23/21

Facebook Rises On Price Target Increase, While Alibaba Falls on Regulatory Concern

Weekly Archive

Christina Siegel Malbon | 07/19/21

Opportunity Equity Update for Week Ended 7/16/21

Alibaba Rises on Potential Collaboration with Tencent While Norwegian Declines on Delta Variant Concerns

Quarterly Market Review

Christina Siegel Malbon | 07/13/21

Quarterly Market Review 2Q 2021

Christina Siegel, CFA covers the market highlights from 2Q 2021.

Weekly Archive

Christina Siegel Malbon | 07/12/21

Opportunity Equity Update for Week Ended 7/9/21

Amazon Rises on Pentagon Deal Cancellation, While WW Falls on Morgan Stanley Report

Bill Miller's Historical Letters

Bill Miller | 07/09/21

Bill Miller 2Q 2021 Market Letter

Bill Miller reminds us that while forecasting an unknowable future is a fruitless task, understanding the present conditions offers valuable insights.

Weekly Archive

Christina Siegel Malbon | 07/06/21

Opportunity Equity Update for Week Ended 7/2/21

Facebook Rises on FTC Complaint Dismissal, While Acuity Brands Falls on Market Guidance

Weekly Archive

Christina Siegel Malbon | 06/29/21

Opportunity Equity Update for Week Ended 6/25/21

Diamondback Energy Rises on Positive Reports, While Amazon.com Falls on Unionization Efforts

Weekly Archive

Christina Siegel Malbon | 06/22/21

Opportunity Equity Update for Week Ended 6/18/21

Amazon.com Rises on Strong Sell Side Report, While DXC Technology Falls During Investor Day

Weekly Archive

Christina Siegel Malbon | 06/14/21

Opportunity Equity Update for Week Ended 6/11/21

The RealReal Rises on M&A Speculation While Alibaba Falls on Chinese Tech Fears

Weekly Archive

Christina Siegel Malbon | 06/08/21

Opportunity Equity Update for Week Ended 6/4/21

Desktop Metal Rises on Price Target Increase While Delta Falls on Updated Guidance

Weekly Archive

Christina Siegel Malbon | 06/01/21

Opportunity Equity Update for Week Ended 5/28/21

Farfetch Gains on New CEO Compensation Plan, While Teva Falls Despite Licensing Agreement

Weekly Archive

Christina Siegel Malbon | 05/24/21

Opportunity Equity Update for Week Ended 5/21/21

ADT Rises on Greenlight Investment, while Acuity Brands Falls on Acquisition

Weekly Archive

Christina Siegel Malbon | 05/18/21

Opportunity Equity Update for Week Ended 5/14/21

Energy Transfer Rises on Price Target Changes, While the RealReal Falls on Earnings

Weekly Archive

Christina Siegel Malbon | 05/10/21

Opportunity Equity Update for Week Ended 5/7/21

WW International Surges on Optimistic Guidance, while Quotient Falls on Disappointing Results

Weekly Archive

Christina Siegel Malbon | 05/03/21

Opportunity Equity Update for Week Ended 4/30/21

Capital One Gained on 1Q Results While Uber Fell on Driver Classification Concerns

Samantha McLemore's Quarterly Letter

Samantha McLemore | 04/27/21

Learn to Earn!

Opportunity Equity 1Q 2021 Letter: Despite the strong market this quarter, there were key lessons to be learned.

Weekly Archive

Christina Siegel Malbon | 04/26/21

Opportunity Equity Update for Week Ended 4/23/21

Vroom Rises on Rising Used Car Prices, While Teva Falls on Lawsuit Uncertainty

Weekly Archive

Christina Siegel Malbon | 04/19/21

Opportunity Equity Update for Week Ended 4/16/21

Alibaba Rises on Regulatory Settlement, While Norwegian Cruise Lines Falls on Reopening Concerns

Quarterly Market Review

Christina Siegel Malbon | 04/15/21

Quarterly Market Review 1Q 2021

The markets moved higher in the 1st quarter of 2021 while the world entered the race to vaccinate.

Bill Miller's Historical Letters

Bill Miller | 04/14/21

Bill Miller 1Q 2021 Market Letter

Bill Miller uses Sir John Templeton’s helpful framing to understand current investor sentiment.

Weekly Archive

Christina Siegel Malbon | 04/12/21

Opportunity Equity Update for Week Ended 4/9/21

Norwegian Cruise Lines gains on Plans to Restart Service While WW International Falls on Morgan Stanley Downgrade

Weekly Archive

Christina Siegel Malbon | 04/05/21

Opportunity Equity Update for Week Ended 4/1/21

Acuity Brands Gains on Strong Earnings While MetroMile Falls on Earnings

Weekly Archive

Christina Siegel Malbon | 03/29/21

Opportunity Equity Update for Week Ended 3/26/21

Acuity Brands Gains on Upgrade While Discovery Declines on Block Trades

Weekly Archive

Christina Siegel Malbon | 03/23/21

Opportunity Equity Update for Week Ended 3/19/21

Facebook Rises on Positive Shop Data while Uber Falls On Worker Classification

Weekly Archive

Christina Siegel Malbon | 03/16/21

Opportunity Equity Update for Week Ended 3/12/21

Desktop Metal Rebounds on Aluminum Sintering Breakthrough, While Stitch Fix Falls on Earnings

Weekly Archive

Christina Siegel Malbon | 03/09/21

Opportunity Equity Update for Week Ended 3/5/21

Diamondback Energy Surges with Energy Prices, while Vroom Falls on Earnings Disappointment

Weekly Archive

Christina Siegel Malbon | 03/02/21

Opportunity Equity Update for Week Ended 2/26/21

Norwegian Cruise Lines Gain on Strong 2022 Bookings, While ADT Falls on 2021 Guidance

Weekly Archive

Christina Siegel Malbon | 02/22/21

Opportunity Equity Update for Week Ended 2/19/21

Norwegian Cruise Lines Fall on Sailing Delay, While Uber Falls on UK Trial Loss

Weekly Archive

Christina Siegel Malbon | 02/17/21

Opportunity Equity Update for Week Ended 2/12/21

Quotient Technology Rises on Strong Quarterly Performance, Teva Falls on Opioid Settlement Pessimism

Weekly Archive

Christina Siegel Malbon | 02/08/21

Opportunity Equity Update for Week Ended 2/5/21

Desktop Metal Rises on Product Announcement, while DXC Technology Drops on End to Merger Talks

Weekly Archive

Christina Siegel Malbon | 02/01/21

Opportunity Equity Update for Week Ended 1/29/21

Rocket Rises on New National Mortgage Broker Directory, While Taylor Morrison Falls on Disappointing December New Home Sales

Weekly Archive

Christina Siegel Malbon | 01/25/21

Opportunity Equity Update for Week Ended 1/22/21

Stitch Fix Gains as Keybanc Increase Price Target, while Energy Transfer Falls on Fears of Extended Pipeline Closure

Samantha McLemore's Quarterly Letter

Samantha McLemore | 01/22/21

Ain’t No Valuation High Enough to Keep the Market from Lovin’ Growth Stocks!

Opportunity Equity 4Q 2020: Samantha McLemore explains the value opportunity she sees going into the new year in her latest letter.

Weekly Archive

Christina Siegel Malbon | 01/19/21

Opportunity Equity Update for Week Ended 1/15/21

Stitch Fix Gains in Sympathy with POSH IPO, While Precigen Falls Despite Pipeline Progress

Quarterly Market Review

Christina Siegel Malbon | 01/13/21

Quarterly Market Review 4Q 2020

Christina Siegel, CFA wraps up market return drivers for 4Q 2020 and the year.

Weekly Archive

Christina Siegel Malbon | 01/11/21

Opportunity Equity Update for Week Ended 1/8/21

DXC Rises on Takeover Approach, while Genworth Tumbles on Missed Merger Deadline

Bill Miller's Historical Letters

Bill Miller | 01/05/21

Bill Miller 4Q 2020 Market Letter

2020 (finally) came to a close and as we look to 2021, we take the approach to understand the current conditions to see the opportunities.

Weekly Archive

Christina Siegel Malbon | 01/04/21

Opportunity Equity Update for Week Ended 12/31/20

Alibaba Rises on Stock Buyback Increase, while Taylor Morrison Falls on Housing Data

Weekly Archive

Christina Siegel Malbon | 12/29/20

Opportunity Equity Update for Week Ended 12/24/20

Uber Rises on Positive Data, while Alibaba Falls on Regulatory Pressure

Weekly Archive

Christina Siegel Malbon | 12/21/20

Opportunity Equity Update for Week Ended 12/18/20

Stitch Fix Gains on Price Target Increases, While UBER Falls Despite Upgrades

Weekly Archive

Christina Siegel Malbon | 12/14/20

Opportunity Equity Update for Week Ended 12/11/20

Stitch Fix Soars on Earnings Beat While WW Falls as Oprah Sells

Weekly Archive

Christina Siegel Malbon | 12/07/20

Opportunity Equity Update for Week Ended 12/4/20

Uber Rises on Analyst Upgrades while Stitch Fix Falls on Rating Downgrade

Weekly Archive

Christina Siegel Malbon | 11/30/20

Opportunity Equity Update for Week Ended 11/27/20

Farfetch Rises on Analyst Upgrade while Genworth Falls on Deal Concerns

Weekly Archive

Christina Siegel Malbon | 11/24/20

Opportunity Equity Update for Week Ended 11/20/20

Discovery Rises on Plans for Streaming Service While CVS Falls on Competition from Amazon.com

Weekly Archive

Christina Siegel Malbon | 11/16/20

Opportunity Equity Update for Week Ended 11/13/20

Farfetch Rises on Strong Earnings While Alibaba Falls on Regulatory Action

Weekly Archive

Christina Siegel Malbon | 11/10/20

Opportunity Equity Update for Week Ended 11/6/20

Farfetch Gains Alibaba and Richemont Investment While Quotient Falls on Disappointing Guidance

Weekly Archive

Christina Siegel Malbon | 11/02/20

Opportunity Equity Update for Week Ended 10/30/20

Puretech Gains on Potential ADS Listing While Uber Falls Ahead of Prop 22 Vote

Samantha McLemore's Quarterly Letter

Samantha McLemore | 10/30/20

Long Term + Value = Winning Potential

Opportunity Equity 3Q 2020 Letter

Weekly Archive

Christina Siegel Malbon | 10/26/20

Opportunity Equity Update for Week Ended 10/23/20

Farfetch Gains In Sympathy with Luxury Earnings, While Taylor Morrison Falls on Below Expectations Housing Data

Weekly Archive

Christina Siegel Malbon | 10/20/20

Opportunity Equity Update for Week Ended 10/16/20

Flexion Gain on Sales Preannouncement, While Precigen Falls Despite FDA Approval

Bill Miller's Historical Letters

Bill Miller | 10/14/20

Bill Miller 3Q 2020 Market Letter

Bill Miller looks at The Fed’s past and present actions to understand the dynamics between the stock and bond market.

Quarterly Market Review

Christina Siegel Malbon | 10/12/20

Quarterly Market Review 3Q 2020

The markets continued to rise in the COVID-strained environment, while the geo-political scene heated up battles over TikToK and the upcoming US election.

Weekly Archive

Christina Siegel Malbon | 10/12/20

Opportunity Equity Update for Week Ended 10/9/20

Precigen Soars on Increased Stake by Merck KGaA, While Vroom Falls on New Underperform Rating

Weekly Archive

Christina Siegel Malbon | 10/05/20

Opportunity Equity Update for Week Ended 10/2/20

DXC Gains on Health and Human Services Sale, Flexion Falls on Minimal News

Weekly Archive

Christina Siegel Malbon | 09/28/20

Opportunity Equity Update for Week Ended 9/25/20

Vroom Gains on Analyst Upgrade, DXC Technology Falls Below 50-day Moving Average

Weekly Archive

Christina Siegel Malbon | 09/21/20

Opportunity Equity Update for Week Ended 9/18/20

BHC Gains on Business Update, ADT Falls on Secondary Equity Offering

Weekly Archive

Christina Siegel Malbon | 09/14/20

Opportunity Equity Update for Week Ended 9/11/20

RH Gains on Strong Earnings, Vroom Falls on Equity Raise

Weekly Archive

Christina Siegel Malbon | 09/08/20

Opportunity Equity Update for Week Ended 9/4/20

Genworth Soars on Transaction Optimism, while Farfetch Falls

Weekly Archive

Christina Siegel Malbon | 08/31/20

Opportunity Equity Update for Week Ended 8/28/20

Worday Surges on Strong Earnings and Outlook, While Farfetch Falls as They Welcome a New Competitor

Weekly Archive

Christina Siegel Malbon | 08/24/20

Opportunity Equity Update for Week Ended 8/21/20

Precigen Gains on Therapy Development Progress, While Teva Drops on DOJ Lawsuit

Weekly Archive

Christina Siegel Malbon | 08/17/20

Opportunity Equity Update for Week Ended 8/14/20

Farfetch Gains on 2Q Results While Teva Falls on Missed 2Q

Weekly Archive

Christina Siegel Malbon | 08/10/20

Opportunity Equity Update for Week Ended 8/7/20

ADT Gains on Google Partnership While Bausch Falls on Separation Announcement

Weekly Archive

Christina Siegel Malbon | 08/03/20

Opportunity Equity Update for Week Ended 7/31/20

Farfetch Gains on Price Target Increases While Boeing Declines on 2Q Earnings

Weekly Archive

Christina Siegel Malbon | 07/27/20

Opportunity Equity Update for Week Ended 7/24/20

Peloton Gains on Price Target Increase While Stitch Fix Falls Below 50-day Moving Average

Samantha McLemore's Quarterly Letter

Samantha McLemore | 07/22/20

Extreme Times Call for Nothing Extreme at All

Opportunity Equity 2Q 2020: Exercising discipline during extreme market swings is the best path towards long-term returns. Samantha McLemore explains.

Weekly Archive

Christina Siegel Malbon | 07/20/20

Opportunity Equity Update for Week Ended 7/17/20

Taylor Morrison Home Corp Gains on Strong June Housing Data While Amazon, Tech Lags

Weekly Archive

Christina Siegel Malbon | 07/13/20

Opportunity Equity Update for Week Ended 7/10/20

Farfetch Gains on Price Target Increase While Energy Transfer Falls on Dakota Access Pipeline Shutdown

Bill Miller's Historical Letters

Bill Miller | 07/10/20

Bill Miller 2Q 2020 Market Letter

The market’s behavior since the March 23rd bottom to the July 2nd level has confounded most observers, from the novice investor to the most experienced and savvy.

Quarterly Market Review

Christina Siegel Malbon | 07/09/20

Quarterly Market Review 2Q 2020

While stocks and bonds ended on high notes for 2Q of 2020, the world battled for a path forward in this pandemic-plagued period.

Weekly Archive

Christina Siegel Malbon | 07/06/20

Opportunity Equity Update for Week Ended 7/2/20

Farfetch Gains Price Target Increases While Teva Falls on Price Fixing Concerns

Weekly Archive

Christina Siegel Malbon | 06/29/20

Opportunity Equity Update for Week Ended 6/26/20

Farfetch Gains on Updated Guidance While Facebook Falls as Boycott Increases

Weekly Archive

Christina Siegel Malbon | 06/22/20

Opportunity Equity Update for Week Ended 6/19/20

Bausch Gains on Raised Price Target While United Falls on New Financing

Weekly Archive

Christina Siegel Malbon | 06/15/20

Opportunity Equity Update for Week Ended 6/12/20

Farfetch Gains on Expected Market Share Gains While Endo Falls on Opioid Concerns

Weekly Archive

Christina Siegel Malbon | 06/08/20

Opportunity Equity Update for Week Ended 6/5/20

Airlines Gain on Better Summer Outlook While Workday Down on Minimal News

Weekly Archive

Christina Siegel Malbon | 06/01/20

Opportunity Equity Update for Week Ended 5/29/20

Flexion Gains on Guggenheim Buy Rating While Ziopharm Falls as their President Leaves

Weekly Archive

Christina Siegel Malbon | 05/26/20

Opportunity Equity Update for Week Ended 5/22/20

RH Gains on JPMorgan Report While Alibaba Falls on Senate Bill

Weekly Archive

Christina Siegel Malbon | 05/18/20

Opportunity Equity Update for Week Ended 5/15/20

Peloton Gains on 1M Connected Fitness Subs While Farfetch Declines on 1Q Results

Weekly Archive

Christina Siegel Malbon | 05/11/20

Opportunity Equity Update for Week Ended 5/8/20

Farfetch Gains Following Capital Raise While Quotient Falls on 1Q Results

Weekly Archive

Christina Siegel Malbon | 05/04/20

Opportunity Equity Update for Week Ended 5/1/20

Homebuilders Gain in Sympathy with DR Horton While Amazon Declines on COVID Expenses

Weekly Archive

Christina Siegel Malbon | 04/27/20

Opportunity Equity Update for Week Ended 4/24/20

Samantha McLemore's Quarterly Letter

Samantha McLemore | 04/27/20

Be Greedy When Others Are Fearful

The first quarter of 2020 brought disastrous news of a global pandemic causing stocks, including ours, to suffer immensely. Through the market’s peak on February 19th, things looked okay.

Weekly Archive

Christina Siegel Malbon | 04/20/20

Opportunity Equity Update for Week Ended 4/17/20

Farfetch Gains on Preliminary 1Q20 results While Banks Fall on Earnings

Bill Miller's Historical Letters

Bill Miller | 04/20/20

Bill Miller 1Q 2020 Market Letter

There have been 4 great stock market buying opportunities in my lifetime. The coronavirus has given us the 5th. Here's Bill Miller's latest market perspective.

Weekly Archive

Christina Siegel Malbon | 04/13/20

Opportunity Equity Update for Week Ended 4/9/20

Farfetch Climbs on Analyst Report While Peloton Declines on Pausing of Live Classes

Quarterly Market Review

Christina Siegel Malbon | 04/09/20

Quarterly Market Review 1Q 2020

An overview of the markets’ movement in the tumultuous and unprecedented 1st quarter of 2020.

Weekly Archive

Christina Siegel Malbon | 04/06/20

Opportunity Equity Update for Week Ended 4/3/20

Teva Gains on FDA Approval of Emergency Covid Treatment While Airlines Decline on High Cash Burn

Weekly Archive

Christina Siegel Malbon | 03/30/20

Opportunity Equity Update for Week Ended 3/27/20

Airlines Climb on CARE Act Passage While Stitch Fix Down on Warehouse Closures

Weekly Archive

Christina Siegel Malbon | 03/24/20

Opportunity Equity Update for Week Ended 3/20/20

Peloton Gains as Gyms Close While Airlines Decline on Lower Demand

News

Samantha McLemore | 03/20/20

Know Your Names, Stay the Course

Samantha McLemore goes back to basics in times turmoil, looking to Ben Graham for insights and staying close to the names in the portfolios.

Weekly Archive

Christina Siegel Malbon | 03/16/20

Opportunity Equity Update for Week Ended 3/13/20

GTY Technology Warrants Gain on Solid Q4 While Stich-Fix Falls on Lower Guidance

Bill Miller's Historical Letters

Bill Miller | 03/16/20

How Markets as Complex Adaptive Systems Process COVID-19

Bill Miller reminds us that markets are complex adaptive systems that are constantly processing real-time information.

Weekly Archive

Christina Siegel Malbon | 03/09/20

Opportunity Equity Update for Week Ended 3/6/20

Genworth Up on NYC Agreement in Principal While Brighthouse Decline on Fed Rate Cut

Weekly Archive

Christina Siegel Malbon | 03/02/20

Opportunity Equity Update for Week Ended 2/28/20

Peloton Up on At-Home-Fitness Focus from Coronavirus While American Airlines Down on Negative Travel Impact from Coronavirus

Bill Miller's Historical Letters

Bill Miller | 03/02/20

Market Uncertainty over Coronavirus

A perspective on the rising concerns over coronavirus and the market turmoil over the past week.

Weekly Archive

Christina Siegel Malbon | 02/25/20

Opportunity Equity Update for Week Ended 2/21/20

Teva’s Price Target Raised at UBS While Tivity Falls on Disappointing Results and Guidance

Weekly Archive

Christina Siegel Malbon | 02/18/20

Opportunity Equity Update for Week Ended 2/14/20

OneMain Gains After 4Q Results While Quotient Falls on 2020 Guidance

Weekly Archive

Christina Siegel Malbon | 02/10/20

Opportunity Equity Update for Week Ended 2/7/20

Teva and Endo Up on Opioid Settlement Optimism While Ziopharm Down on Equity Raise

Weekly Archive

Christina Siegel Malbon | 02/03/20

Opportunity Equity Update for Week Ended 1/31/20

Amazon Climbs After Strong Earnings While Facebook Falls on 1Q Deceleration

Weekly Archive

Christina Siegel Malbon | 01/27/20

Opportunity Equity Update for Week Ended 1/24/20

Lennar Gains on December Home Sales While Alibaba Falls on Coronavirus Fears

Weekly Archive

Christina Siegel Malbon | 01/21/20

Opportunity Equity Update for Week Ended 1/17/20

Endo and Teva Gain on Perrigo Earnings and Opioid Settlement Speculation While Flexion Falls Below the 50-Day

Samantha McLemore's Quarterly Letter

Samantha McLemore | 01/19/20

The Perils of Rearview Mirror Investing

Opportunity Equity 4Q 2019: It's easy to get caught up in the short-term narrative, but that's rarely the best approach for long-term gains.

Quarterly Market Review

Christina Siegel Malbon | 01/14/20

Quarterly Market Review 4Q 2019

Stocks had a strong 4Q and ended the year on a high note. Christina Siegel recaps the market driver highlights from the quarter and the year.

Weekly Archive

Christina Siegel Malbon | 01/13/20

Opportunity Equity Update for Week Ended 1/10/20

Lennar Gains on Strong Earnings While ADT Falls on Defenders Acquisition

Bill Miller's Historical Letters

Bill Miller | 01/13/20

Bill Miller 4Q 2019 Market Letter

What’s the reality of the risk in the market versus the general sentiment and how can we think about that differential going forward? Bill Miller's market perspective.

Weekly Archive

Christina Siegel Malbon | 01/06/20

Opportunity Equity Update for Week Ended 1/3/20

Endo Raised to Overweight at Piper Jaffray While American Airlines Falls on Oil Price Spike

Weekly Archive

Christina Siegel Malbon | 12/30/19

Opportunity Equity Update for Week Ended 12/27/19

Flexion Gains on Revised Zilretta Label While OneMain Dropped from Stephen’s 2020 Best Ideas List

Weekly Archive

Christina Siegel Malbon | 12/23/19

Opportunity Equity Update for Week Ended 12/20/19

Medifast Gains on Take-out Rumors While Quotient Declines on New Sell Rating

Weekly Archive

Christina Siegel Malbon | 12/16/19

Opportunity Equity Update for Week Ended 12/13/19

Genworth Gains on Canadian Sale Approval While Tivity Declines on Dawn’s Surprise Departure

Weekly Archive

Christina Siegel Malbon | 12/09/19

Opportunity Equity Update for Week Ended 12/6/19

RH Gains on Strong 3Q Results While Opioid Names Fall on Renewed Concerns

Weekly Archive

Christina Siegel Malbon | 12/02/19

Opportunity Equity Update for Week Ended 11/29/19

Peloton Soars on Reports of Strong Holiday Traffic While Intrexon Falls Below its 50-Day Moving Average

Weekly Archive

Christina Siegel Malbon | 11/25/19

Opportunity Equity Update for Week Ended 11/22/19

Discovery Gains on Malone Purchase While Qualcomm Declines on Disappointing Guidance

Investor Insights

Samantha McLemore | 11/25/19

How Sensible Capital Allocation Helps Drive A Stock Higher

Contrasting FB and AAPL to see how sensible capital allocation helps drive a stock higher.

Weekly Archive

Christina Siegel Malbon | 11/18/19

Opportunity Equity Update for Week Ended 11/15/19

Weekly Archive

Christina Siegel Malbon | 11/12/19

Opportunity Equity Update for Week Ended 11/8/19

Quotient Gains on 3Q Beat While Medifast Falls on 3Q Disappointment

Weekly Archive

Christina Siegel Malbon | 11/04/19

Opportunity Equity Update for Week Ended 11/1/19

Bausch Gains on New Outperform Rating While Lennar and Pulte Lower

Weekly Archive

Christina Siegel Malbon | 10/28/19

Opportunity Equity Update for Week Ended 10/25/19

American Up on 3Q EPS Beat While Endo is Down on No Additional Progress Towards Global Opioid Settlement

Weekly Archive

Christina Siegel Malbon | 10/21/19

Opportunity Equity Update for Week Ended 10/18/19

Endo Up on Potential Opioid Settlement While Ziopharm Down on Negative Article

Samantha McLemore's Quarterly Letter

Samantha McLemore | 10/21/19

“All we need is just a little patience”

Opportunity Equity 3Q 2019: One of the most difficult parts of investing is managing emotions that make us want to do the wrong thing at the wrong time.

Bill Miller's Historical Letters

Bill Miller | 10/16/19

Bill Miller 3Q 2019 Market Letter

The market is a swirling cacophony of competing stories, and which ones an investor believes in and acts on determines investment results. Bill Miller's market perspective.

Weekly Archive

Christina Siegel Malbon | 10/14/19

Opportunity Equity Update for Week Ended 10/11/19

Stitch Fix Inc. Crosses Above the 50-day While Eventbrite Falls Below the 50-day

Quarterly Market Review

Christina Siegel Malbon | 10/09/19

Quarterly Market Review 3Q 2019

Value shined in September, but bond proxies led the S&P 500 sector returns for the quarter. Trade wars continued and the Fed lowers rates twice. A summary of the highlights from the 3Q.

Weekly Archive

Christina Siegel Malbon | 10/07/19

Opportunity Equity Update for Week Ended 10/4/19

Endo International Rises Above its 100-Day Moving Average While Bausch Health Falls on Xifaxan Suit

Weekly Archive

Christina Siegel Malbon | 09/30/19

Opportunity Equity Update for Week Ended 9/27/19

RH Gains on Price Target Increase While Micron Declines on Disappointing Guidance

Weekly Archive

Christina Siegel Malbon | 09/23/19

Opportunity Equity Update for Week Ended 9/20/19

ADT Gains After Presenting at Goldman Conference While American Falls on Higher Oil Prices

Weekly Archive

Christina Siegel Malbon | 09/16/19

Opportunity Equity Update for Week Ended 9/13/19

RH Gains on 2Q Beat and Raise While Facebook Declines

News

| 09/10/19

Navigating Short-term Volatility. An Interview with Samantha McLemore

In a recent interview, Samantha McLemore talks about the challenges and opportunities of being a value investor in volatile markets.

Weekly Archive

Christina Siegel Malbon | 09/09/19

Opportunity Equity Update for Week Ended 9/6/19

Endo Up on CCH FDA Submission While Mallinckrodt Down on Hiring of Restructuring Consultants

Weekly Archive

Christina Siegel Malbon | 09/03/19

Opportunity Equity Update for Week Ended 8/30/19

Flexion Up on Continued Zilretta Acceleration While Alexion Down on Soliris Patent Challenge

What We are Reading

| 08/27/19

Reading List - Fall 2019

Back to school is in the air. Here are a few things to add to your fall reading list.

Weekly Archive

Christina Siegel Malbon | 08/26/19

Opportunity Equity Update for Week Ended 8/23/19

Endo Up on Ohio Opioid Settlement While Intrexon Falls Below 100 and 200-day Moving Average

News

| 08/20/19

Samantha McLemore and Consuelo Mack Talk Long-term Investing

There's a lot packed into this interview - everything from the financial crisis to Amazon to fundamentals versus expectations. Here's an excerpt of the highlights.

Weekly Archive

Christina Siegel Malbon | 08/19/19

Opportunity Equity Update for Week Ended 8/16/19

Genworth Gains on Canadian Sale While Ziopharm Declines

Weekly Archive

Christina Siegel Malbon | 08/12/19

Opportunity Equity Update for Week Ended 8/9/19

Flexion Gains on 2Q Results While Quotient Falls on 2Q Earnings

Weekly Archive

Christina Siegel Malbon | 08/05/19

Opportunity Equity Update for Week Ended 8/2/19

Ziopharm Gains with $45M Raise While Brighthouse Financial Falls on Rate Cut

Bill Miller's Historical Letters

Bill Miller | 08/02/19

It's About Expectations

A few comments on the Fed's recent rate cut.

Weekly Archive

Christina Siegel Malbon | 07/29/19

Opportunity Equity Update for Week Ended 7/26/19

Ziopharm Rises with New CFO While Flexion Falls on Price Target Decline

Weekly Archive

Christina Siegel Malbon | 07/22/19

Opportunity Equity Update for Week Ended 7/19/19

Eventbrite Crosses the 50-day Moving Average While Endo, Teva and Mallinckrodt Fall on Opioid Concerns

Samantha McLemore's Quarterly Letter

Samantha McLemore | 07/22/19

The Greatly Exaggerated Death of Value Investing

Opportunity Equity 2Q19 Letter: When we talk about value, we focus on the present value of the future free cash flows, which is the value of any business.

Weekly Archive

Christina Siegel Malbon | 07/15/19

Opportunity Equity Update for Week Ended 7/12/19

MU Gains on Japan’s New Restrictions While BHC and ALXN Fall Below the 50, 100 and 200-day Moving Average

Bill Miller's Historical Letters

Bill Miller | 07/10/19

Bill Miller 2Q 2019 Market Letter

Good news, bads news and market news. Bill Miller's current market perspective.

Quarterly Market Review

Christina Siegel Malbon | 07/09/19

Quarterly Market Review 2Q 2019

Recap of 2Q 2019. A choppy quarter with large-caps and growth names leading.

Weekly Archive

Christina Siegel Malbon | 07/08/19

Opportunity Equity Update for Week Ended 7/5/19

RH Gains on Tariff Truce While Flexion Falls Below 50 and 100-day Moving Average

Weekly Archive

Christina Siegel Malbon | 07/01/19

Opportunity Equity Update for Week Ended 6/28/19

Micron Advances On Strong Earnings Results While Lennar Falls on Weaker Outlook

Weekly Archive

Christina Siegel Malbon | 06/24/19

Opportunity Equity Update for Week Ended 6/21/19

Genworth Crosses 50-day Moving Average While ADT Falls Below 50-day Moving Average

Weekly Archive

Christina Siegel Malbon | 06/17/19

Opportunity Equity Update for Week Ended 6/14/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 06/10/19

Opportunity Equity Update for Week Ended 6/7/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 06/03/19

Opportunity Equity Update for Week Ended 5/31/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 05/28/19

Opportunity Equity Update for Week Ended 5/24/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 05/20/19

Opportunity Equity Update for Week Ended 5/17/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 05/13/19

Opportunity Equity Update for Week Ended 5/10/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 05/06/19

Opportunity Equity Update for Week Ended 5/3/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 04/29/19

Opportunity Equity Update for Week Ended 4/26/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 04/22/19

Opportunity Equity Update for Week Ended 4/18/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Samantha McLemore's Quarterly Letter

Samantha McLemore | 04/22/19

It Pays to Be a Price and Value Investor

Opportunity Equity 1Q 2019 Letter: Sir John Templeton distinguishes between outlook/trend and price/value investors. How being the latter, plus a little patience, can pay off over the long term.

Bill Miller's Historical Letters

Bill Miller | 04/17/19

Some Reflections on the Bull at 10

The bull market crossed the 10-year mark on 3/9/19. Bill Miller reflects on how we navigated this period.

Weekly Archive

Christina Siegel Malbon | 04/15/19

Opportunity Equity Update for Week Ended 4/12/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 04/08/19

Opportunity Equity Update for Week Ended 4/5/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Quarterly Market Review

Christina Siegel Malbon | 04/08/19

Quarterly Market Review 1Q 2019

Recap of 1Q 2019. Stocks soared, all S&P sectors were up, the 35-day government shut down and more.

Weekly Archive

Christina Siegel Malbon | 04/01/19

Opportunity Equity Update for Week Ended 3/29/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 03/25/19

Opportunity Equity Update for Week Ended 3/22/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 03/18/19

Opportunity Equity Update for Week Ended 3/15/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 03/11/19

Opportunity Equity Update for Week Ended 3/8/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 03/04/19

Opportunity Equity Update for Week Ended 3/1/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 02/25/19

Opportunity Equity Update for Week Ended 2/22/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 02/19/19

Opportunity Equity Update for Week Ended 2/15/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 02/11/19

Opportunity Equity Update for Week Ended 2/8/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 02/04/19

Opportunity Equity Update for Week Ended 2/1/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Samantha McLemore's Quarterly Letter

Samantha McLemore | 01/30/19

Do you know the worst rerun?

Opportunity Equity 4Q 2018 Letter: The only good news about the terrible month and horrible quarter: it’s a rerun of a show we’ve seen before.

Weekly Archive

Christina Siegel Malbon | 01/28/19

Opportunity Equity Update for Week Ended 1/25/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 01/22/19

Opportunity Equity Update for Week Ended 1/18/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 01/14/19

Opportunity Equity Update for Week Ended 1/11/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Bill Miller's Historical Letters

Bill Miller | 01/10/19

Bill Miller 4Q 2018 Market Letter

It takes courage to be a pig.

Quarterly Market Review

Christina Siegel Malbon | 01/09/19

Quarterly Market Review 4Q 2018

Recap of 4Q 2018 and how the market ended the year.

Weekly Archive

Christina Siegel Malbon | 01/07/19

Opportunity Equity Update for Week Ended 1/4/19

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 12/31/18

Opportunity Equity Update for Week Ended 12/28/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 12/24/18

Opportunity Equity Update for Week Ended 12/21/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 12/18/18

Opportunity Equity Update for Week Ended 12/14/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 12/10/18

Opportunity Equity Update for Week Ended 12/7/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 12/03/18

Opportunity Equity Update for Week Ended 11/30/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 11/26/18

Opportunity Equity Update for Week Ended 11/23/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 11/19/18

Opportunity Equity Update for Week Ended 11/16/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Bill Miller's Historical Letters

Bill Miller | 11/19/18

Bill Miller: Market Observations

Highlights from our 3Q18 investor call: We try to understand the interaction between actual fundamentals and people’s beliefs about what’s going to happen.

Weekly Archive

Christina Siegel Malbon | 11/12/18

Opportunity Equity Update for Week Ended 11/9/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 11/05/18

Opportunity Equity Update for Week Ended 11/2/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 10/29/18

Opportunity Equity Update for Week Ended 10/26/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Bill Miller's Historical Letters

Bill Miller | 10/24/18

Rolling Realized Value into New Ideas

Opportunity Equity 3Q 2018 Letter: Selling to fund more opportunistic names marked the activity this quarter.

Weekly Archive

Christina Siegel Malbon | 10/22/18

Opportunity Equity Update for Week Ended 10/19/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 10/15/18

Opportunity Equity Update for Week Ended 10/12/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Bill Miller's Historical Letters

Bill Miller | 10/10/18

Bill Miller 3Q 2018 Market Letter

The most important thing that happened to the stock market this quarter is what happened to the bond market.

Quarterly Market Review

Christina Siegel Malbon | 10/09/18

Quarterly Market Review 3Q 2018

Recap of 3Q 2018 and how the market ended the quarter

Weekly Archive

Christina Siegel Malbon | 10/08/18

Opportunity Equity Update for Week Ended 10/5/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 10/01/18

Opportunity Equity Update for Week Ended 9/28/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 09/24/18

Opportunity Equity Update for Week Ended 9/21/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 09/17/18

Opportunity Equity Update for Week Ended 9/14/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 09/10/18

Opportunity Equity Update for Week Ended 9/7/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 09/04/18

Opportunity Equity Update for Week Ended 8/31/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 08/27/18

Opportunity Equity Update for Week Ended 8/24/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 08/20/18

Opportunity Equity Update for Week Ended 8/17/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 08/13/18

Opportunity Equity Update for Week Ended 8/10/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 08/06/18

Opportunity Equity Update for Week Ended 8/3/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 07/30/18

Opportunity Equity Update for Week Ended 7/27/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 07/23/18

Opportunity Equity Update for Week Ended 7/20/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Samantha McLemore's Quarterly Letter

Samantha McLemore | 07/19/18

"You got to know when to hold 'em"

Opportunity Equity 2Q 2018 Letter: Reversion to the mean is a powerful force in markets, as long-term investors well understand

Bill Miller's Historical Letters

Bill Miller | 07/18/18

Bill Miller 2Q 2018 Market Letter

Scaling the wall of worry as the market climbs higher.

Weekly Archive

Christina Siegel Malbon | 07/16/18

Opportunity Equity Update for Week Ended 7/13/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Quarterly Market Review

Christina Siegel Malbon | 07/09/18

Quarterly Market Review 2Q 2018

Recap of 1Q 2018 and how the market ended the quarter

Weekly Archive

Christina Siegel Malbon | 07/09/18

Opportunity Equity Update for Week Ended 7/6/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

What We are Reading

| 07/09/18

2018 Summer Reading

A snapshot of what our team's reading right now.

Weekly Archive

Christina Siegel Malbon | 07/02/18

Opportunity Equity Update for Week Ended 6/29/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 06/25/18

Opportunity Equity Update for Week Ended 6/22/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 06/18/18

Opportunity Equity Update for Week Ended 6/15/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 06/11/18

Opportunity Equity Update for Week Ended 6/8/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 06/04/18

Opportunity Equity Update for Week Ended 6/1/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 05/29/18

Opportunity Equity Update for Week Ended 5/25/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 05/21/18

Opportunity Equity Update for Week Ended 5/18/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Investor Insights

Samantha McLemore | 05/15/18

Regulating Emotions 3000 feet off the Ground

Alex Honnold's take on risk versus consequence provides perspective for long term investors.

Weekly Archive

Christina Siegel Malbon | 05/14/18

Opportunity Equity Update for Week Ended 5/11/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 05/07/18

Opportunity Equity Update for Week Ended 5/4/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 04/30/18

Opportunity Equity Update for Week Ended 4/27/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 04/23/18

Opportunity Equity Update for Week Ended 4/20/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Samantha McLemore's Quarterly Letter

Samantha McLemore | 04/18/18

The Story Follows the Price

Opportunity Equity 1Q 2018 Letter: The good news about the recent pressure on market pries is that buying at lower prices improves long-term returns.

Bill Miller's Historical Letters

Bill Miller | 04/18/18

Bill Miller 1Q 2018 Market Letter

The market this year looks, acts and feels different, and rightly so.

Weekly Archive

Christina Siegel Malbon | 04/16/18

Opportunity Equity Update for Week Ended 4/13/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 04/09/18

Opportunity Equity Update for Week Ended 4/6/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Quarterly Market Review

Christina Siegel Malbon | 04/05/18

Quarterly Market Review 1Q 2018

Recap of 1Q 2018 and how the market ended the quarter

Weekly Archive

Christina Siegel Malbon | 04/02/18

Opportunity Equity Update for Week Ended 3/29/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Investor Insights

Samantha McLemore | 03/27/18

6 Questions on Opportunity Equity

Samantha McLemore covers monetizing volatility, being long-term oriented and viewing growth as an input to value in this short interview.

Weekly Archive

Christina Siegel Malbon | 03/26/18

Opportunity Equity Update for Week Ended 3/23/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 03/19/18

Opportunity Equity Update for Week Ended 3/16/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

News

| 03/13/18

Active versus Passive: A Recap of the Debate between Bill Miller and Charles Ellis

Bill Miller and Mr. Ellis acknowledge that there are challenges to investing in actively managed strategies, and each offer their perspective on how to evaluate managers.

Weekly Archive

Christina Siegel Malbon | 03/12/18

Opportunity Equity Update for Week Ended 3/9/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

News

Bill Miller | 03/08/18

Bill Miller on Philosophy: An Interview

Philosophy has undoubtedly influenced Bill Miller in his life and career. In this excerpt from a recent interview with APA, Bill talks about it.

Weekly Archive

Christina Siegel Malbon | 03/05/18

Opportunity Equity Update for Week Ended 3/2/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 02/26/18

Opportunity Equity Update for Week Ended 2/23/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 02/20/18

Opportunity Equity Update for Week Ended 2/16/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 02/12/18

Opportunity Equity Update for Week Ended 2/9/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 02/05/18

Opportunity Equity Update for Week Ended 2/2/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 01/29/18

Opportunity Equity Update for Week Ended 1/26/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Samantha McLemore's Quarterly Letter

Samantha McLemore | 01/23/18

The Value of Doing Nothing

Opportunity Equity 4Q 2017 Letter: A path to generating superior long-term results is to buy the dips, not sell the strength.

Bill Miller's Historical Letters

Bill Miller | 01/23/18

Bill Miller's 4Q 2017 Market Letter

2017 was a year that surprised and rewarded investors in stocks.

Weekly Archive

Christina Siegel Malbon | 01/22/18

Opportunity Equity Update for Week Ended 1/19/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Quarterly Market Review

Christina Siegel Malbon | 01/18/18

Quarterly Market Review 4Q 2017

Highlights of the market movements in 4Q and for the year 2017.

Weekly Archive

Christina Siegel Malbon | 01/16/18

Opportunity Equity Update for Week Ended 1/12/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 01/08/18

Opportunity Equity Update for Week Ended 1/5/18

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 01/02/18

Opportunity Equity Update for Week Ended 12/29/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 12/27/17

Opportunity Equity Update for Week Ended 12/22/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 12/18/17

Opportunity Equity Update for Week Ended 12/15/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 12/11/17

Opportunity Equity Update for Week Ended 12/8/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 12/04/17

Opportunity Equity Update for Week Ended 12/1/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 11/27/17

Opportunity Equity Update for Week Ended 11/24/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 11/20/17

Opportunity Equity Update for Week Ended 11/17/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 11/13/17

Opportunity Equity Update for Week Ended 11/10/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Investor Insights

Christina Siegel Malbon | 11/07/17

The Power of the Millennial

Taking a deeper look at sustainability and factors that may influence how Millennials invest their increasing wealth.

What We are Reading

| 11/07/17

November 2017 Reading List

A list of what our team is reading and listening to right now.

Weekly Archive

Christina Siegel Malbon | 11/06/17

Opportunity Equity Update for Week Ended 11/3/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Bill Miller's Historical Letters

Bill Miller | 11/02/17

“Certitude is not the test of certainty. We have been cocksure of many things that were not so.” - Oliver Wendell Holmes

The Financial industry’s murderers’ row issues their pessimistic opinion on Bitcoin. Here are some reasons to be on the other side of the trade.

Weekly Archive

Christina Siegel Malbon | 10/30/17

Opportunity Equity Update for Week Ended 10/27/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 10/23/17

Opportunity Equity Update for Week Ended 10/20/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Samantha McLemore's Quarterly Letter

Samantha McLemore | 10/19/17

Still Finding Great Values

Long-term investors must remember Benjamin Graham’s famous insight: “In the short run, the market is a voting machine but in the long run, it is a weighing machine.”

Bill Miller's Historical Letters

Bill Miller | 10/18/17

Bill Miller's 3Q 2017 Market Letter

We continue to be in a bull market.

Quarterly Market Review

Christina Siegel Malbon | 10/16/17

Quarterly Market Review 3Q 2017

Highlights of the market movements in 3Q 2017

Weekly Archive

Christina Siegel Malbon | 10/16/17

Opportunity Equity Update for Week Ended 10/13/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 10/09/17

Opportunity Equity Update for Week Ended 10/6/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 10/02/17

Opportunity Equity Update for Week Ended 9/29/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 09/25/17

Opportunity Equity Update for Week Ended 9/22/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 09/18/17

Opportunity Equity Update for Week Ended 9/15/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 09/11/17

Opportunity Equity Update for Week Ended 9/8/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 09/05/17

Opportunity Equity Update for Week Ended 9/1/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 08/28/17

Opportunity Equity Update for Week Ended 8/25/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 08/21/17

Opportunity Equity Update for Week Ended 8/18/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 08/14/17

Opportunity Equity Update for Week Ended 8/11/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 08/07/17

Opportunity Equity Update for Week Ended 8/4/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 07/31/17

Opportunity Equity Update for Week Ended 7/28/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Portfolio Activity and Attribution

Christina Siegel Malbon | 07/26/17

Opportunity Equity 2Q 2017 Portfolio Activity and Attribution

Opportunity Equity Highlights and Market Commentary for 2Q 2017

Samantha McLemore's Quarterly Letter

Samantha McLemore | 07/26/17

In a World of Trend and Momentum, Long-Term Value Suffers

It again rings true that the best time to invest is after a period of poor performance and to hold on patiently for the long term.

Weekly Archive

Christina Siegel Malbon | 07/24/17

Opportunity Equity Update for Week Ended 7/21/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Bill Miller's Historical Letters

Bill Miller | 07/18/17

Nine years into a bull market for stocks and it looks to remain so. Bill Miller shares insights from Reminiscences of a Stock Operator.

Nine years into a bull market for stocks and it looks to remain so. Bill Miller shares insights from Reminiscences of a Stock Operator.

Weekly Archive

Christina Siegel Malbon | 07/17/17

Opportunity Equity Update for Week Ended 7/14/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 07/10/17

Opportunity Equity Update for Week Ended 7/7/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 07/03/17

Opportunity Equity Update for Week Ended 6/30/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 06/26/17

Opportunity Equity Update for Week Ended 6/23/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 06/19/17

Opportunity Equity Update for Week Ended 6/16/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 06/12/17

Opportunity Equity Update for Week Ended 6/9/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 06/05/17

Opportunity Equity Update for Week Ended 6/2/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 05/30/17

Opportunity Equity Update for Week Ended 5/26/17

Endo Pharmaceuticals crosses 100-day moving average while Alexion Pharmaceuticals moves lower on management shakeup

Weekly Archive

Christina Siegel Malbon | 05/22/17

Opportunity Equity Update for Week Ended 5/19/17

OneMain Holdings moves up after earnings announcement, While Pangaea moves down

Weekly Archive

Christina Siegel Malbon | 05/15/17

Opportunity Equity Update for Week Ended 5/12/17

OneMain Holdings moves up after earnings announcement, While Pangaea moves down

Weekly Archive

Christina Siegel Malbon | 05/08/17

Opportunity Equity Update for Week Ended 5/5/17

OneMain Holdings moves up after earnings announcement, While Pangaea moves down

Weekly Archive

Christina Siegel Malbon | 05/01/17

Opportunity Equity Update for Week Ended 4/28/17

OneMain Holdings moves up after earnings announcement, While Pangaea moves down

Weekly Archive

Christina Siegel Malbon | 04/24/17

Opportunity Equity Update for Week Ended 4/21/17

OneMain Holdings moves up after earnings announcement, While Pangaea moves down

Bill Miller's Historical Letters

Bill Miller | 04/21/17

Finding Value in Patience

In this just-in-time market, long term investors are finding value in patience.

Portfolio Activity and Attribution

Christina Siegel Malbon | 04/21/17

Opportunity Equity 1Q 2017 Portfolio Activity and Attribution

Opportunity Equity Highlights and Market Commentary for 1Q 2017

Weekly Archive

Christina Siegel Malbon | 04/17/17

Opportunity Equity Update for Week Ended 4/13/17

OneMain Holdings moves up after earnings announcement, While Pangaea moves down

Bill Miller's Historical Letters

Bill Miller | 04/11/17

Thoughts from Sir John

I am reminded of something Sir John Templeton told me several decades ago. He said that there are two types of investors in the world: “outlook and trend” investors and “price and value” investors.